Proactiveinvestors USA & Canada Pressure BioSciences, Inc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Pressure BioSciences, Inc. RSS feed en Wed, 30 Sep 2020 19:55:20 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Pressure BioSciences and Leica Microsystems team up to co-market pivotal cancer workflow technology https://www.proactiveinvestors.com/companies/news/923129/pressure-biosciences-and-leica-microsystems-team-up-to-co-market-pivotal-cancer-workflow-technology-923129.html Tue, 30 Jun 2020 15:32:00 -0400 https://www.proactiveinvestors.com/companies/news/923129/pressure-biosciences-and-leica-microsystems-team-up-to-co-market-pivotal-cancer-workflow-technology-923129.html Pressure BioSciences merger partner receives $3.5 million order for hand sanitizer product https://www.proactiveinvestors.com/companies/news/921715/pressure-biosciences-merger-partner-receives-35-million-order-for-hand-sanitizer-product-921715.html Thu, 11 Jun 2020 14:10:00 -0400 https://www.proactiveinvestors.com/companies/news/921715/pressure-biosciences-merger-partner-receives-35-million-order-for-hand-sanitizer-product-921715.html Pressure BioSciences eyeing around $2.4 million in 1Q 2021 as it sells its first manufacturing run of BaroShear K45 systems https://www.proactiveinvestors.com/companies/news/921177/pressure-biosciences-eyeing-around-24-million-in-1q-2021-as-it-sells-its-first-manufacturing-run-of-baroshear-k45-systems-921177.html Thu, 04 Jun 2020 14:35:00 -0400 https://www.proactiveinvestors.com/companies/news/921177/pressure-biosciences-eyeing-around-24-million-in-1q-2021-as-it-sells-its-first-manufacturing-run-of-baroshear-k45-systems-921177.html Pressure BioSciences merger partner Cannaworx to launch hemp immune boosting product in mid-July https://www.proactiveinvestors.com/companies/news/920645/pressure-biosciences-merger-partner-cannaworx-to-launch-hemp-immune-boosting-product-in-mid-july-920645.html Thu, 28 May 2020 14:20:00 -0400 https://www.proactiveinvestors.com/companies/news/920645/pressure-biosciences-merger-partner-cannaworx-to-launch-hemp-immune-boosting-product-in-mid-july-920645.html Pressure BioSciences says Cannaworx in potential deal to acquire Five Leaf Labs in Louisiana https://www.proactiveinvestors.com/companies/news/919979/pressure-biosciences-says-cannaworx-in-potential-deal-to-acquire-five-leaf-labs-in-louisiana-919979.html Tue, 19 May 2020 19:05:00 -0400 https://www.proactiveinvestors.com/companies/news/919979/pressure-biosciences-says-cannaworx-in-potential-deal-to-acquire-five-leaf-labs-in-louisiana-919979.html Pressure Biosciences to launch hand sanitizer after rebranding to Availa Bio in triple merger https://www.proactiveinvestors.com/companies/news/919613/pressure-biosciences-to-launch-hand-sanitizer-after-rebranding-to-availa-bio-in-triple-merger-919613.html Thu, 14 May 2020 13:45:00 -0400 https://www.proactiveinvestors.com/companies/news/919613/pressure-biosciences-to-launch-hand-sanitizer-after-rebranding-to-availa-bio-in-triple-merger-919613.html Pressure BioSciences, rebranding to Availa Bio after mergers, taps former L'Oréal President Jim Morrison as CEO https://www.proactiveinvestors.com/companies/news/919116/pressure-biosciences-rebranding-to-availa-bio-after-mergers-taps-former-l-oral-president-jim-morrison-as-ceo-919116.html Thu, 07 May 2020 14:35:00 -0400 https://www.proactiveinvestors.com/companies/news/919116/pressure-biosciences-rebranding-to-availa-bio-after-mergers-taps-former-l-oral-president-jim-morrison-as-ceo-919116.html Pressure BioSciences to rebrand as Avalia Bio following merger with Cannaworx and SkinScience Labs https://www.proactiveinvestors.com/companies/news/918876/pressure-biosciences-to-rebrand-as-avalia-bio-following-merger-with-cannaworx-and-skinscience-labs-918876.html Tue, 05 May 2020 14:30:00 -0400 https://www.proactiveinvestors.com/companies/news/918876/pressure-biosciences-to-rebrand-as-avalia-bio-following-merger-with-cannaworx-and-skinscience-labs-918876.html Pressure Biosciences boosted as it announces deal to acquire SkinScience Labs and award-winning products https://www.proactiveinvestors.com/companies/news/918562/pressure-biosciences-boosted-as-it-announces-deal-to-acquire-skinscience-labs-and-award-winning-products-918562.html Thu, 30 Apr 2020 15:19:00 -0400 https://www.proactiveinvestors.com/companies/news/918562/pressure-biosciences-boosted-as-it-announces-deal-to-acquire-skinscience-labs-and-award-winning-products-918562.html Pressure Biosciences to acquire Cannaworx, apply signature oil-processing tech to hemp CBD products https://www.proactiveinvestors.com/companies/news/918435/pressure-biosciences-to-acquire-cannaworx-apply-signature-oil-processing-tech-to-hemp-cbd-products-918435.html Wed, 29 Apr 2020 15:20:00 -0400 https://www.proactiveinvestors.com/companies/news/918435/pressure-biosciences-to-acquire-cannaworx-apply-signature-oil-processing-tech-to-hemp-cbd-products-918435.html Pressure BioSciences and RedShiftBio join forces to create biopharmaceutical development tool https://www.proactiveinvestors.com/companies/news/917448/pressure-biosciences-and-redshiftbio-join-forces-to-create-biopharmaceutical-development-tool-917448.html Thu, 16 Apr 2020 18:07:00 -0400 https://www.proactiveinvestors.com/companies/news/917448/pressure-biosciences-and-redshiftbio-join-forces-to-create-biopharmaceutical-development-tool-917448.html Pressure BioSciences wins order from new customer for its Ultra Shear Technology platform to process CBD oil https://www.proactiveinvestors.com/companies/news/914870/pressure-biosciences-wins-order-from-new-customer-for-its-ultra-shear-technology-platform-to-process-cbd-oil-914870.html Thu, 12 Mar 2020 15:01:00 -0400 https://www.proactiveinvestors.com/companies/news/914870/pressure-biosciences-wins-order-from-new-customer-for-its-ultra-shear-technology-platform-to-process-cbd-oil-914870.html Pressure BioSciences opens Ultra Shear Technology Demonstration Lab for CBD oil processing https://www.proactiveinvestors.com/companies/news/913868/pressure-biosciences-opens-ultra-shear-technology-demonstration-lab-for-cbd-oil-processing-913868.html Thu, 27 Feb 2020 14:59:00 -0500 https://www.proactiveinvestors.com/companies/news/913868/pressure-biosciences-opens-ultra-shear-technology-demonstration-lab-for-cbd-oil-processing-913868.html Pressure BioSciences gets high-upside price target from Zacks after scoring big Ultra Shear Technology order https://www.proactiveinvestors.com/companies/news/912463/pressure-biosciences-gets-high-upside-price-target-from-zacks-after-scoring-big-ultra-shear-technology-order-912463.html Fri, 07 Feb 2020 19:31:00 -0500 https://www.proactiveinvestors.com/companies/news/912463/pressure-biosciences-gets-high-upside-price-target-from-zacks-after-scoring-big-ultra-shear-technology-order-912463.html Pressure BioSciences unveils bench-top CBD oil-processing device for launch in 3Q 2020 https://www.proactiveinvestors.com/companies/news/911878/pressure-biosciences-unveils-bench-top-cbd-oil-processing-device-for-launch-in-3q-2020-911878.html Thu, 30 Jan 2020 14:53:00 -0500 https://www.proactiveinvestors.com/companies/news/911878/pressure-biosciences-unveils-bench-top-cbd-oil-processing-device-for-launch-in-3q-2020-911878.html Pressure BioSciences shares rocket on CBD-oil processing systems purchase order from Las Vegas cannabis CEO https://www.proactiveinvestors.com/companies/news/911480/pressure-biosciences-shares-rocket-on-cbd-oil-processing-systems-purchase-order-from-las-vegas-cannabis-ceo-911480.html Fri, 24 Jan 2020 20:03:00 -0500 https://www.proactiveinvestors.com/companies/news/911480/pressure-biosciences-shares-rocket-on-cbd-oil-processing-systems-purchase-order-from-las-vegas-cannabis-ceo-911480.html Pressure BioSciences' Ultra Sheer Technology featured in Cannabis Brightline magazine https://www.proactiveinvestors.com/companies/news/910932/pressure-biosciences--ultra-sheer-technology-featured-in-cannabis-brightline-magazine-910932.html Fri, 17 Jan 2020 16:30:00 -0500 https://www.proactiveinvestors.com/companies/news/910932/pressure-biosciences--ultra-sheer-technology-featured-in-cannabis-brightline-magazine-910932.html Pressure BioSciences's PCT platform featured in more than 20 scientific articles for second year in a row https://www.proactiveinvestors.com/companies/news/910307/pressure-biosciences-s-pct-platform-featured-in-more-than-20-scientific-articles-for-second-year-in-a-row-910307.html Thu, 09 Jan 2020 17:52:00 -0500 https://www.proactiveinvestors.com/companies/news/910307/pressure-biosciences-s-pct-platform-featured-in-more-than-20-scientific-articles-for-second-year-in-a-row-910307.html Pressure BioSciences sees soaring consumables sales in third quarter, projects revenue growth in 2020 https://www.proactiveinvestors.com/companies/news/909577/pressure-biosciences-sees-soaring-consumables-sales-in-third-quarter-projects-revenue-growth-in-2020-909577.html Thu, 19 Dec 2019 20:29:00 -0500 https://www.proactiveinvestors.com/companies/news/909577/pressure-biosciences-sees-soaring-consumables-sales-in-third-quarter-projects-revenue-growth-in-2020-909577.html Zachs: Pressure BioSciences at 'tipping point,' initiates coverage with $4.44 target https://www.proactiveinvestors.com/companies/news/904218/zachs-pressure-biosciences-at--tipping-point--initiates-coverage-with-444-target-904218.html Fri, 04 Oct 2019 19:48:00 -0400 https://www.proactiveinvestors.com/companies/news/904218/zachs-pressure-biosciences-at--tipping-point--initiates-coverage-with-444-target-904218.html Pressure BioSciences PCT instrument deemed ‘essential’ by OB-GYN chair at gynecologic cancer meeting in in Brazil https://www.proactiveinvestors.com/companies/news/904189/pressure-biosciences-pct-instrument-deemed-essential-by-ob-gyn-chair-at-gynecologic-cancer-meeting-in-in-brazil-904189.html Fri, 04 Oct 2019 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/904189/pressure-biosciences-pct-instrument-deemed-essential-by-ob-gyn-chair-at-gynecologic-cancer-meeting-in-in-brazil-904189.html Pressure BioSciences' pressure cycling technology on display at international cancer conference https://www.proactiveinvestors.com/companies/news/903899/pressure-biosciences--pressure-cycling-technology-on-display-at-international-cancer-conference-903899.html Tue, 01 Oct 2019 12:50:00 -0400 https://www.proactiveinvestors.com/companies/news/903899/pressure-biosciences--pressure-cycling-technology-on-display-at-international-cancer-conference-903899.html Pressure BioSciences' pressure cycling technology prominently featured at a major conference in Australia https://www.proactiveinvestors.com/companies/news/903580/pressure-biosciences--pressure-cycling-technology-prominently-featured-at-a-major-conference-in-australia-903580.html Thu, 26 Sep 2019 14:30:00 -0400 https://www.proactiveinvestors.com/companies/news/903580/pressure-biosciences--pressure-cycling-technology-prominently-featured-at-a-major-conference-in-australia-903580.html Pressure BioSciences taps a seasoned financial executive as its new CFO https://www.proactiveinvestors.com/companies/news/902882/pressure-biosciences-taps-a-seasoned-financial-executive-as-its-new-cfo-902882.html Tue, 17 Sep 2019 15:08:00 -0400 https://www.proactiveinvestors.com/companies/news/902882/pressure-biosciences-taps-a-seasoned-financial-executive-as-its-new-cfo-902882.html Pressure BioSciences CEO sees potential opportunity to enter clinical market after recent customer data https://www.proactiveinvestors.com/companies/news/902488/pressure-biosciences-ceo-sees-potential-opportunity-to-enter-clinical-market-after-recent-customer-data-902488.html Wed, 11 Sep 2019 12:29:00 -0400 https://www.proactiveinvestors.com/companies/news/902488/pressure-biosciences-ceo-sees-potential-opportunity-to-enter-clinical-market-after-recent-customer-data-902488.html Pressure BioSciences' PCT technology highlighted in a pair of medical journal articles https://www.proactiveinvestors.com/companies/news/902418/pressure-biosciences--pct-technology-highlighted-in-a-pair-of-medical-journal-articles-902418.html Tue, 10 Sep 2019 20:23:00 -0400 https://www.proactiveinvestors.com/companies/news/902418/pressure-biosciences--pct-technology-highlighted-in-a-pair-of-medical-journal-articles-902418.html Pressure BioSciences signs on two more clients for its water-soluble CBD manufacturing system https://www.proactiveinvestors.com/companies/news/901481/pressure-biosciences-signs-on-two-more-clients-for-its-water-soluble-cbd-manufacturing-system-901481.html Mon, 26 Aug 2019 15:09:00 -0400 https://www.proactiveinvestors.com/companies/news/901481/pressure-biosciences-signs-on-two-more-clients-for-its-water-soluble-cbd-manufacturing-system-901481.html Pressure BioSciences wins two more orders for its novel BaroShear K45 water-soluble CBD manufacturing system https://www.proactiveinvestors.com/companies/news/901344/pressure-biosciences-wins-two-more-orders-for-its-novel-baroshear-k45-water-soluble-cbd-manufacturing-system-901344.html Thu, 22 Aug 2019 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/901344/pressure-biosciences-wins-two-more-orders-for-its-novel-baroshear-k45-water-soluble-cbd-manufacturing-system-901344.html Pressure BioSciences sees record consumables sales in 2Q, momentum from launch of CBD processing system https://www.proactiveinvestors.com/companies/news/900893/pressure-biosciences-sees-record-consumables-sales-in-2q-momentum-from-launch-of-cbd-processing-system-900893.html Thu, 15 Aug 2019 20:05:00 -0400 https://www.proactiveinvestors.com/companies/news/900893/pressure-biosciences-sees-record-consumables-sales-in-2q-momentum-from-launch-of-cbd-processing-system-900893.html Pressure BioSciences gets first customer for its BaroShear water soluble CBD manufacturing device https://www.proactiveinvestors.com/companies/news/314210/pressure-biosciences-gets-first-customer-for-its-baroshear-water-soluble-cbd-manufacturing-device-14210.html Thu, 25 Jul 2019 17:42:00 -0400 https://www.proactiveinvestors.com/companies/news/314210/pressure-biosciences-gets-first-customer-for-its-baroshear-water-soluble-cbd-manufacturing-device-14210.html Pressure BioSciences wins first customer for its water-soluble CBD manufacturing system https://www.proactiveinvestors.com/companies/news/224524/pressure-biosciences-wins-first-customer-for-its-water-soluble-cbd-manufacturing-system-224524.html Thu, 25 Jul 2019 15:55:00 -0400 https://www.proactiveinvestors.com/companies/news/224524/pressure-biosciences-wins-first-customer-for-its-water-soluble-cbd-manufacturing-system-224524.html Pressure BioSciences wins protein manufacturing contract, enters $44bln protein processing market https://www.proactiveinvestors.com/companies/news/314196/pressure-biosciences-wins-protein-manufacturing-contract-enters-44bln-protein-processing-market-14196.html Wed, 24 Jul 2019 20:02:00 -0400 https://www.proactiveinvestors.com/companies/news/314196/pressure-biosciences-wins-protein-manufacturing-contract-enters-44bln-protein-processing-market-14196.html Pressure BioSciences inks second protein manufacturing contract with multi-billion dollar biotherapeutics company https://www.proactiveinvestors.com/companies/news/224446/pressure-biosciences-inks-second-protein-manufacturing-contract-with-multi-billion-dollar-biotherapeutics-company-224446.html Wed, 24 Jul 2019 20:02:00 -0400 https://www.proactiveinvestors.com/companies/news/224446/pressure-biosciences-inks-second-protein-manufacturing-contract-with-multi-billion-dollar-biotherapeutics-company-224446.html Pressure BioSciences launches BaroShear K45 system to manufacture water-soluble CBD https://www.proactiveinvestors.com/companies/news/222978/pressure-biosciences-launches-baroshear-k45-system-to-manufacture-water-soluble-cbd-222978.html Thu, 27 Jun 2019 16:45:00 -0400 https://www.proactiveinvestors.com/companies/news/222978/pressure-biosciences-launches-baroshear-k45-system-to-manufacture-water-soluble-cbd-222978.html Pressure BioSciences pulls off milestone, advances processing method for keeping food and drinks shelf-stable https://www.proactiveinvestors.com/companies/news/222879/pressure-biosciences-pulls-off-milestone-advances-processing-method-for-keeping-food-and-drinks-shelf-stable-222879.html Wed, 26 Jun 2019 15:30:00 -0400 https://www.proactiveinvestors.com/companies/news/222879/pressure-biosciences-pulls-off-milestone-advances-processing-method-for-keeping-food-and-drinks-shelf-stable-222879.html Pressure BioSciences eyes strong revenue from three blockbuster pressure-based technology platforms https://www.proactiveinvestors.com/companies/news/222942/pressure-biosciences-eyes-strong-revenue-from-three-blockbuster-pressure-based-technology-platforms-222942.html Wed, 26 Jun 2019 10:00:00 -0400 https://www.proactiveinvestors.com/companies/news/222942/pressure-biosciences-eyes-strong-revenue-from-three-blockbuster-pressure-based-technology-platforms-222942.html Pressure BioSciences ultra high-pressure HUB platform shines in food safety studies https://www.proactiveinvestors.com/companies/news/222441/pressure-biosciences-ultra-high-pressure-hub-platform-shines-in-food-safety-studies-222441.html Wed, 19 Jun 2019 17:50:00 -0400 https://www.proactiveinvestors.com/companies/news/222441/pressure-biosciences-ultra-high-pressure-hub-platform-shines-in-food-safety-studies-222441.html Spotlight on Pressure BioSciences' PCT platform at major international science summit https://www.proactiveinvestors.com/companies/news/221995/spotlight-on-pressure-biosciences--pct-platform-at-major-international-science-summit-221995.html Wed, 12 Jun 2019 16:20:00 -0400 https://www.proactiveinvestors.com/companies/news/221995/spotlight-on-pressure-biosciences--pct-platform-at-major-international-science-summit-221995.html Pressure BioSciences 1Q revenue boosted by new BioPharma contract services, Ultra Shear Technology platform https://www.proactiveinvestors.com/companies/news/220458/pressure-biosciences-1q-revenue-boosted-by-new-biopharma-contract-services-ultra-shear-technology-platform-220458.html Thu, 16 May 2019 20:00:00 -0400 https://www.proactiveinvestors.com/companies/news/220458/pressure-biosciences-1q-revenue-boosted-by-new-biopharma-contract-services-ultra-shear-technology-platform-220458.html Pressure BioSciences CEO Richard Schumacher to step down in September, company outlines succession plan https://www.proactiveinvestors.com/companies/news/219502/pressure-biosciences-ceo-richard-schumacher-to-step-down-in-september-company-outlines-succession-plan-219502.html Wed, 01 May 2019 17:27:00 -0400 https://www.proactiveinvestors.com/companies/news/219502/pressure-biosciences-ceo-richard-schumacher-to-step-down-in-september-company-outlines-succession-plan-219502.html Pressure BioSciences 4Q revenue surges from new biopharma services, UST Shear Technology https://www.proactiveinvestors.com/companies/news/219136/pressure-biosciences-4q-revenue-surges-from-new-biopharma-services-ust-shear-technology-219136.html Thu, 25 Apr 2019 19:29:00 -0400 https://www.proactiveinvestors.com/companies/news/219136/pressure-biosciences-4q-revenue-surges-from-new-biopharma-services-ust-shear-technology-219136.html Pressure BioSciences showcases abilities of Ultra Shear Technology platform to improve CBD oil https://www.proactiveinvestors.com/companies/news/217787/pressure-biosciences-showcases-abilities-of-ultra-shear-technology-platform-to-improve-cbd-oil-217787.html Tue, 02 Apr 2019 10:05:00 -0400 https://www.proactiveinvestors.com/companies/news/217787/pressure-biosciences-showcases-abilities-of-ultra-shear-technology-platform-to-improve-cbd-oil-217787.html Pressure BioSciences shares jump after life sciences company sets up Center of Excellence at NYU lab https://www.proactiveinvestors.com/companies/news/217341/pressure-biosciences-shares-jump-after-life-sciences-company-sets-up-center-of-excellence-at-nyu-lab-217341.html Wed, 27 Mar 2019 14:13:00 -0400 https://www.proactiveinvestors.com/companies/news/217341/pressure-biosciences-shares-jump-after-life-sciences-company-sets-up-center-of-excellence-at-nyu-lab-217341.html Pressure BioSciences teams up with German research organization on disease-fighting antibodies https://www.proactiveinvestors.com/companies/news/215731/pressure-biosciences-teams-up-with-german-research-organization-on-disease-fighting-antibodies-215731.html Mon, 04 Mar 2019 14:47:00 -0500 https://www.proactiveinvestors.com/companies/news/215731/pressure-biosciences-teams-up-with-german-research-organization-on-disease-fighting-antibodies-215731.html Tests show Pressure BioSciences' Ultra Shear Technology effective for processing CBD oil https://www.proactiveinvestors.com/companies/news/215079/tests-show-pressure-biosciences--ultra-shear-technology-effective-for-processing-cbd-oil-215079.html Thu, 21 Feb 2019 18:20:00 -0500 https://www.proactiveinvestors.com/companies/news/215079/tests-show-pressure-biosciences--ultra-shear-technology-effective-for-processing-cbd-oil-215079.html Pressure BioSciences and NutraFuels form collaboration on nutraceuticals https://www.proactiveinvestors.com/companies/news/312122/pressure-biosciences-and-nutrafuels-form-collaboration-on-nutraceuticals-12122.html Wed, 06 Feb 2019 13:05:00 -0500 https://www.proactiveinvestors.com/companies/news/312122/pressure-biosciences-and-nutrafuels-form-collaboration-on-nutraceuticals-12122.html Pressure BioSciences and NutraFuels strike deal to collaborate on nutraceuticals https://www.proactiveinvestors.com/companies/news/213629/pressure-biosciences-and-nutrafuels-strike-deal-to-collaborate-on-nutraceuticals-213629.html Wed, 30 Jan 2019 14:25:00 -0500 https://www.proactiveinvestors.com/companies/news/213629/pressure-biosciences-and-nutrafuels-strike-deal-to-collaborate-on-nutraceuticals-213629.html Pressure BioSciences says more than 20 scientific papers cited benefits of PCT platform https://www.proactiveinvestors.com/companies/news/312008/pressure-biosciences-says-more-than-20-scientific-papers-cited-benefits-of-pct-platform-12008.html Mon, 28 Jan 2019 18:12:00 -0500 https://www.proactiveinvestors.com/companies/news/312008/pressure-biosciences-says-more-than-20-scientific-papers-cited-benefits-of-pct-platform-12008.html Pressure Bioscience makes key hire to help move company forward in 2019 https://www.proactiveinvestors.com/companies/news/311734/pressure-bioscience-makes-key-hire-to-help-move-company-forward-in-2019-11734.html Tue, 08 Jan 2019 17:41:00 -0500 https://www.proactiveinvestors.com/companies/news/311734/pressure-bioscience-makes-key-hire-to-help-move-company-forward-in-2019-11734.html Pressure BioSciences kicks off the commercial launch of its biopharmaceuticals contract services business https://www.proactiveinvestors.com/companies/news/212073/pressure-biosciences-kicks-off-the-commercial-launch-of-its-biopharmaceuticals-contract-services-business-212073.html Mon, 07 Jan 2019 14:25:00 -0500 https://www.proactiveinvestors.com/companies/news/212073/pressure-biosciences-kicks-off-the-commercial-launch-of-its-biopharmaceuticals-contract-services-business-212073.html Pressure BioSciences PCT platform could play pivotal role in improving cancer diagnosis https://www.proactiveinvestors.com/companies/news/311667/pressure-biosciences-pct-platform-could-play-pivotal-role-in-improving-cancer-diagnosis-11667.html Wed, 19 Dec 2018 18:30:00 -0500 https://www.proactiveinvestors.com/companies/news/311667/pressure-biosciences-pct-platform-could-play-pivotal-role-in-improving-cancer-diagnosis-11667.html Pressure BioSciences' PCT platform could play key role in improving cancer diagnosis https://www.proactiveinvestors.com/companies/news/211423/pressure-biosciences--pct-platform-could-play-key-role-in-improving-cancer-diagnosis-211423.html Tue, 18 Dec 2018 15:19:00 -0500 https://www.proactiveinvestors.com/companies/news/211423/pressure-biosciences--pct-platform-could-play-key-role-in-improving-cancer-diagnosis-211423.html Pressure BioSciences reaches 3 new milestones, including inroads in CBD oil https://www.proactiveinvestors.com/companies/news/311244/pressure-biosciences-reaches-3-new-milestones-including-inroads-in-cbd-oil-11244.html Wed, 21 Nov 2018 17:04:00 -0500 https://www.proactiveinvestors.com/companies/news/311244/pressure-biosciences-reaches-3-new-milestones-including-inroads-in-cbd-oil-11244.html US businesses of all sizes and stripes feel the pinch from President Trump's trade tariffs https://www.proactiveinvestors.com/companies/news/209401/us-businesses-of-all-sizes-and-stripes-feel-the-pinch-from-president-trump-s-trade-tariffs-209401.html Fri, 16 Nov 2018 19:07:00 -0500 https://www.proactiveinvestors.com/companies/news/209401/us-businesses-of-all-sizes-and-stripes-feel-the-pinch-from-president-trump-s-trade-tariffs-209401.html Pressure BioSciences' Ultra Shear Technology system may solve the cannabinoid delivery issue https://www.proactiveinvestors.com/companies/news/208951/pressure-biosciences--ultra-shear-technology-system-may-solve-the-cannabinoid-delivery-issue-208951.html Thu, 15 Nov 2018 19:30:00 -0500 https://www.proactiveinvestors.com/companies/news/208951/pressure-biosciences--ultra-shear-technology-system-may-solve-the-cannabinoid-delivery-issue-208951.html Pressure BioSciences posts 3Q revenue from new scientific services group, lowers operating expenses https://www.proactiveinvestors.com/companies/news/209290/pressure-biosciences-posts-3q-revenue-from-new-scientific-services-group-lowers-operating-expenses-209290.html Thu, 15 Nov 2018 12:39:00 -0500 https://www.proactiveinvestors.com/companies/news/209290/pressure-biosciences-posts-3q-revenue-from-new-scientific-services-group-lowers-operating-expenses-209290.html Pressure BioSciences taps industry veteran Bradford Young as chief commercial officer https://www.proactiveinvestors.com/companies/news/208762/pressure-biosciences-taps-industry-veteran-bradford-young-as-chief-commercial-officer-208762.html Wed, 07 Nov 2018 16:13:00 -0500 https://www.proactiveinvestors.com/companies/news/208762/pressure-biosciences-taps-industry-veteran-bradford-young-as-chief-commercial-officer-208762.html Pressure BioSciences accelerates development of its Ultra Shear Technology pressure-based platform to target new markets https://www.proactiveinvestors.com/companies/news/206321/pressure-biosciences-accelerates-development-of-its-ultra-shear-technology-pressure-based-platform-to-target-new-markets-206321.html Wed, 03 Oct 2018 14:40:00 -0400 https://www.proactiveinvestors.com/companies/news/206321/pressure-biosciences-accelerates-development-of-its-ultra-shear-technology-pressure-based-platform-to-target-new-markets-206321.html Pressure BioSciences' ultra-high pressure products featured in Chicago food tech conference https://www.proactiveinvestors.com/companies/news/205353/pressure-biosciences-ultra-high-pressure-products-featured-in-chicago-food-tech-conference-205353.html Thu, 20 Sep 2018 14:15:00 -0400 https://www.proactiveinvestors.com/companies/news/205353/pressure-biosciences-ultra-high-pressure-products-featured-in-chicago-food-tech-conference-205353.html Pressure BioSciences shares jump on sales of first two HUB 880 Explorer research instruments https://www.proactiveinvestors.com/companies/news/204861/pressure-biosciences-shares-jump-on-sales-of-first-two-hub-880-explorer-research-instruments-204861.html Thu, 13 Sep 2018 16:32:00 -0400 https://www.proactiveinvestors.com/companies/news/204861/pressure-biosciences-shares-jump-on-sales-of-first-two-hub-880-explorer-research-instruments-204861.html Pressure BioSciences receives a US patent for a new high-pressure flow-through microfluidic sample preparation device https://www.proactiveinvestors.com/companies/news/203904/pressure-biosciences-receives-a-us-patent-for-a-new-high-pressure-flow-through-microfluidic-sample-preparation-device-203904.html Thu, 30 Aug 2018 18:00:00 -0400 https://www.proactiveinvestors.com/companies/news/203904/pressure-biosciences-receives-a-us-patent-for-a-new-high-pressure-flow-through-microfluidic-sample-preparation-device-203904.html Pressure BioSciences posts record 2Q product and services revenue, lowers operating expenses https://www.proactiveinvestors.com/companies/news/202979/pressure-biosciences-posts-record-2q-product-and-services-revenue-lowers-operating-expenses-202979.html Wed, 15 Aug 2018 15:24:00 -0400 https://www.proactiveinvestors.com/companies/news/202979/pressure-biosciences-posts-record-2q-product-and-services-revenue-lowers-operating-expenses-202979.html Pressure BioSciences expects to win additional patents for its Ultra Sheer Technology pressure-based platform https://www.proactiveinvestors.com/companies/news/202606/pressure-biosciences-expects-to-win-additional-patents-for-its-ultra-sheer-technology-pressure-based-platform-202606.html Thu, 09 Aug 2018 16:30:00 -0400 https://www.proactiveinvestors.com/companies/news/202606/pressure-biosciences-expects-to-win-additional-patents-for-its-ultra-sheer-technology-pressure-based-platform-202606.html Pressure BioSciences developing breakthrough processing method for shelf-stable milk, dairy products https://www.proactiveinvestors.com/companies/news/201166/pressure-biosciences-developing-breakthrough-processing-method-for-shelf-stable-milk-dairy-products-201166.html Thu, 19 Jul 2018 15:00:00 -0400 https://www.proactiveinvestors.com/companies/news/201166/pressure-biosciences-developing-breakthrough-processing-method-for-shelf-stable-milk-dairy-products-201166.html Ohio State scientists to use Pressure BioSciences's Ultra Shear Technology to sterilize 'clean label' food and drinks https://www.proactiveinvestors.com/companies/news/200622/ohio-state-scientists-to-use-pressure-biosciences-s-ultra-shear-technology-to-sterilize-clean-label-food-and-drinks-200622.html Thu, 12 Jul 2018 17:36:00 -0400 https://www.proactiveinvestors.com/companies/news/200622/ohio-state-scientists-to-use-pressure-biosciences-s-ultra-shear-technology-to-sterilize-clean-label-food-and-drinks-200622.html Pressure BioSciences, The Ohio State University researchers team up to revolutionize food safety https://www.proactiveinvestors.com/companies/news/309836/pressure-biosciences-the-ohio-state-university-researchers-team-up-to-revolutionize-food-safety-9836.html Thu, 12 Jul 2018 17:27:00 -0400 https://www.proactiveinvestors.com/companies/news/309836/pressure-biosciences-the-ohio-state-university-researchers-team-up-to-revolutionize-food-safety-9836.html Pressure BioSciences has an eye toward uplisting as it strengthens balance sheet https://www.proactiveinvestors.com/companies/news/309648/pressure-biosciences-has-an-eye-toward-uplisting-as-it-strengthens-balance-sheet-9648.html Thu, 21 Jun 2018 15:26:00 -0400 https://www.proactiveinvestors.com/companies/news/309648/pressure-biosciences-has-an-eye-toward-uplisting-as-it-strengthens-balance-sheet-9648.html 'We run Pressure BioSciences as if we were on Nasdaq or NYSE,' says CEO https://www.proactiveinvestors.com/companies/news/199064/-we-run-pressure-biosciences-as-if-we-were-on-nasdaq-or-nyse-says-ceo-199064.html Mon, 18 Jun 2018 14:49:00 -0400 https://www.proactiveinvestors.com/companies/news/199064/-we-run-pressure-biosciences-as-if-we-were-on-nasdaq-or-nyse-says-ceo-199064.html Pressure BioSciences invigorates its balance sheet, converts additional US$7.24mln of debt into equity https://www.proactiveinvestors.com/companies/news/198715/pressure-biosciences-invigorates-its-balance-sheet-converts-additional-us724mln-of-debt-into-equity-198715.html Tue, 12 Jun 2018 14:50:00 -0400 https://www.proactiveinvestors.com/companies/news/198715/pressure-biosciences-invigorates-its-balance-sheet-converts-additional-us724mln-of-debt-into-equity-198715.html Pressure BioSciences CEO sees increased revenue on projects and services in 2018 https://www.proactiveinvestors.com/companies/news/309331/pressure-biosciences-ceo-sees-increased-revenue-on-projects-and-services-in-2018 Fri, 18 May 2018 15:42:00 -0400 https://www.proactiveinvestors.com/companies/news/309331/pressure-biosciences-ceo-sees-increased-revenue-on-projects-and-services-in-2018 Callitas Health, ChemioCare and Pressure BioSciences make a splash at Proactive Investors forum https://www.proactiveinvestors.com/companies/news/197230/callitas-health-chemiocare-and-pressure-biosciences-make-a-splash-at-proactive-investors-forum-197230.html Fri, 18 May 2018 11:00:00 -0400 https://www.proactiveinvestors.com/companies/news/197230/callitas-health-chemiocare-and-pressure-biosciences-make-a-splash-at-proactive-investors-forum-197230.html Pressure BioSciences shares soar on shrinking debt and jump in first-quarter revenue https://www.proactiveinvestors.com/companies/news/197036/pressure-biosciences-shares-soar-on-shrinking-debt-and-jump-in-first-quarter-revenue-197036.html Tue, 15 May 2018 18:56:00 -0400 https://www.proactiveinvestors.com/companies/news/197036/pressure-biosciences-shares-soar-on-shrinking-debt-and-jump-in-first-quarter-revenue-197036.html Pressure Biosciences chief bullish on sale of new PreEMT platform https://www.proactiveinvestors.com/companies/news/196748/pressure-biosciences-chief-bullish-on-sale-of-new-preemt-platform-196748.html Thu, 10 May 2018 12:51:00 -0400 https://www.proactiveinvestors.com/companies/news/196748/pressure-biosciences-chief-bullish-on-sale-of-new-preemt-platform-196748.html Pressure BioSciences reaches a deal to contract out its PreEMT platform https://www.proactiveinvestors.com/companies/news/196371/pressure-biosciences-reaches-a-deal-to-contract-out-its-preemt-platform-196371.html Thu, 03 May 2018 16:02:00 -0400 https://www.proactiveinvestors.com/companies/news/196371/pressure-biosciences-reaches-a-deal-to-contract-out-its-preemt-platform-196371.html Pressure BioSciences CEO says company poised for 'solid year' in 2018 https://www.proactiveinvestors.com/companies/news/194662/pressure-biosciences-ceo-says-company-poised-for-solid-year-in-2018-194662.html Tue, 10 Apr 2018 16:30:00 -0400 https://www.proactiveinvestors.com/companies/news/194662/pressure-biosciences-ceo-says-company-poised-for-solid-year-in-2018-194662.html Pressure BioSciences reports 20% bump in 4Q sales, expects continued growth in its main business https://www.proactiveinvestors.com/companies/news/194189/pressure-biosciences-reports-20-bump-in-4q-sales-expects-continued-growth-in-its-main-business-194189.html Wed, 04 Apr 2018 11:00:00 -0400 https://www.proactiveinvestors.com/companies/news/194189/pressure-biosciences-reports-20-bump-in-4q-sales-expects-continued-growth-in-its-main-business-194189.html Pressure BioSciences chief presents rosy view of growth prospects in podast interview https://www.proactiveinvestors.com/companies/news/193096/pressure-biosciences-chief-presents-rosy-view-of-growth-prospects-in-podast-interview-193096.html Tue, 13 Mar 2018 20:42:00 -0400 https://www.proactiveinvestors.com/companies/news/193096/pressure-biosciences-chief-presents-rosy-view-of-growth-prospects-in-podast-interview-193096.html Pressure BioSciences expecting sales boost from new co-marketing deal with ISS https://www.proactiveinvestors.com/companies/news/191662/pressure-biosciences-expecting-sales-boost-from-new-co-marketing-deal-with-iss-191662.html Wed, 14 Feb 2018 16:20:00 -0500 https://www.proactiveinvestors.com/companies/news/191662/pressure-biosciences-expecting-sales-boost-from-new-co-marketing-deal-with-iss-191662.html Pressure BioSciences expecting banner year for the company in 2018 https://www.proactiveinvestors.com/companies/news/190776/pressure-biosciences-expecting-banner-year-for-the-company-in-2018-190776.html Mon, 29 Jan 2018 18:07:00 -0500 https://www.proactiveinvestors.com/companies/news/190776/pressure-biosciences-expecting-banner-year-for-the-company-in-2018-190776.html Pressure BioSciences says software upgrade enhances Barocycler 2320EXT instrument https://www.proactiveinvestors.com/companies/news/189111/pressure-biosciences-says-software-upgrade-enhances-barocycler-2320ext-instrument-189111.html Wed, 20 Dec 2017 16:51:00 -0500 https://www.proactiveinvestors.com/companies/news/189111/pressure-biosciences-says-software-upgrade-enhances-barocycler-2320ext-instrument-189111.html Pressure BioSciences expects BaroFold Inc to have "significant" impact on revenues in 2018 https://www.proactiveinvestors.com/companies/news/188823/pressure-biosciences-expects-barofold-inc-to-have-significant-impact-on-revenues-in-2018-188823.html Thu, 14 Dec 2017 17:22:00 -0500 https://www.proactiveinvestors.com/companies/news/188823/pressure-biosciences-expects-barofold-inc-to-have-significant-impact-on-revenues-in-2018-188823.html Zacks upbeat on Pressure BioSciences' growth potential; targets US$10 a share https://www.proactiveinvestors.com/companies/news/187932/zacks-upbeat-on-pressure-biosciences-growth-potential-targets-us10-a-share-187932.html Wed, 29 Nov 2017 12:36:00 -0500 https://www.proactiveinvestors.com/companies/news/187932/zacks-upbeat-on-pressure-biosciences-growth-potential-targets-us10-a-share-187932.html Pressure BioSciences moves towards profitability as it reveals strong revenue growth in latest quarter https://www.proactiveinvestors.com/companies/news/187254/pressure-biosciences-moves-towards-profitability-as-it-reveals-strong-revenue-growth-in-latest-quarter-187254.html Tue, 14 Nov 2017 17:37:00 -0500 https://www.proactiveinvestors.com/companies/news/187254/pressure-biosciences-moves-towards-profitability-as-it-reveals-strong-revenue-growth-in-latest-quarter-187254.html Pressure BioSciences bidding to expand into large Chinese life sciences market https://www.proactiveinvestors.com/companies/news/186676/pressure-biosciences-bidding-to-expand-into-large-chinese-life-sciences-market-186676.html Thu, 02 Nov 2017 14:28:00 -0400 https://www.proactiveinvestors.com/companies/news/186676/pressure-biosciences-bidding-to-expand-into-large-chinese-life-sciences-market-186676.html Pressure BioSciences' Schumacher upbeat on market potential for its life science tools https://www.proactiveinvestors.com/companies/news/186218/pressure-biosciences-schumacher-upbeat-on-market-potential-for-its-life-science-tools-186218.html Mon, 30 Oct 2017 18:22:00 -0400 https://www.proactiveinvestors.com/companies/news/186218/pressure-biosciences-schumacher-upbeat-on-market-potential-for-its-life-science-tools-186218.html Pressure BioSciences hires NetworkNewsWire for corporate communications https://www.proactiveinvestors.com/companies/news/186038/pressure-biosciences-hires-networknewswire-for-corporate-communications-186038.html Mon, 23 Oct 2017 19:02:00 -0400 https://www.proactiveinvestors.com/companies/news/186038/pressure-biosciences-hires-networknewswire-for-corporate-communications-186038.html Pressure BioSciences has high hopes for Phasex Corporation collaboration on UST tech https://www.proactiveinvestors.com/companies/news/185825/pressure-biosciences-has-high-hopes-for-phasex-corporation-collaboration-on-ust-tech-185825.html Fri, 20 Oct 2017 22:01:00 -0400 https://www.proactiveinvestors.com/companies/news/185825/pressure-biosciences-has-high-hopes-for-phasex-corporation-collaboration-on-ust-tech-185825.html Pressure BioSciences' latest Barocycler machine's credentials featured at scientific meetings https://www.proactiveinvestors.com/companies/news/185364/pressure-biosciences-latest-barocycler-machine-s-credentials-featured-at-scientific-meetings-185364.html Tue, 10 Oct 2017 20:09:00 -0400 https://www.proactiveinvestors.com/companies/news/185364/pressure-biosciences-latest-barocycler-machine-s-credentials-featured-at-scientific-meetings-185364.html Pressure BioSciences' chief upbeat on company's potential despite recent stock lows https://www.proactiveinvestors.com/companies/news/185360/pressure-biosciences-chief-upbeat-on-company-s-potential-despite-recent-stock-lows-185360.html Tue, 10 Oct 2017 19:49:00 -0400 https://www.proactiveinvestors.com/companies/news/185360/pressure-biosciences-chief-upbeat-on-company-s-potential-despite-recent-stock-lows-185360.html Pressure BioSciences reveals UItra Shear Technology patent news https://www.proactiveinvestors.com/companies/news/184935/pressure-biosciences-reveals-uitra-shear-technology-patent-news-184935.html Mon, 02 Oct 2017 18:39:00 -0400 https://www.proactiveinvestors.com/companies/news/184935/pressure-biosciences-reveals-uitra-shear-technology-patent-news-184935.html Pressure Biosciences' Barocycler instrument named finalist in 2017 R&D 100 awards https://www.proactiveinvestors.com/companies/news/184162/pressure-biosciences-barocycler-instrument-named-finalist-in-2017-rd-100-awards-184162.html Mon, 18 Sep 2017 20:03:00 -0400 https://www.proactiveinvestors.com/companies/news/184162/pressure-biosciences-barocycler-instrument-named-finalist-in-2017-rd-100-awards-184162.html Pressure Biosciences eyes further revenue growth for 2017 after second quarter numbers https://www.proactiveinvestors.com/companies/news/182554/pressure-biosciences-eyes-further-revenue-growth-for-2017-after-second-quarter-numbers-182554.html Wed, 16 Aug 2017 19:35:00 -0400 https://www.proactiveinvestors.com/companies/news/182554/pressure-biosciences-eyes-further-revenue-growth-for-2017-after-second-quarter-numbers-182554.html Pressure Biosciences delighted at collaborator's recognition https://www.proactiveinvestors.com/companies/news/178795/pressure-biosciences-delighted-at-collaborator-s-recognition-178795.html Mon, 05 Jun 2017 20:01:00 -0400 https://www.proactiveinvestors.com/companies/news/178795/pressure-biosciences-delighted-at-collaborator-s-recognition-178795.html Pressure BioSciences announces 1-for-30 stock consolidation https://www.proactiveinvestors.com/companies/news/178731/pressure-biosciences-announces-1-for-30-stock-consolidation-178731.html Fri, 02 Jun 2017 17:02:00 -0400 https://www.proactiveinvestors.com/companies/news/178731/pressure-biosciences-announces-1-for-30-stock-consolidation-178731.html Pressure Biosciences' solid growth expected to continue, says SeeThruEquity https://www.proactiveinvestors.com/companies/news/178274/pressure-biosciences-solid-growth-expected-to-continue-says-seethruequity-178274.html Wed, 24 May 2017 14:41:00 -0400 https://www.proactiveinvestors.com/companies/news/178274/pressure-biosciences-solid-growth-expected-to-continue-says-seethruequity-178274.html Pressure Biosciences' technology is building momentum https://www.proactiveinvestors.com/companies/news/171264/pressure-biosciences-technology-is-building-momentum-171264.html Wed, 17 May 2017 12:36:00 -0400 https://www.proactiveinvestors.com/companies/news/171264/pressure-biosciences-technology-is-building-momentum-171264.html Pressure Biosciences increases revenue and gross margins in first quarter https://www.proactiveinvestors.com/companies/news/177875/pressure-biosciences-increases-revenue-and-gross-margins-in-first-quarter-177875.html Tue, 16 May 2017 19:22:00 -0400 https://www.proactiveinvestors.com/companies/news/177875/pressure-biosciences-increases-revenue-and-gross-margins-in-first-quarter-177875.html Pressure Biosciences names Damasio as finance chief as it travels towards profitability https://www.proactiveinvestors.com/companies/news/176472/pressure-biosciences-names-damasio-as-finance-chief-as-it-travels-towards-profitability-176472.html Mon, 17 Apr 2017 18:04:00 -0400 https://www.proactiveinvestors.com/companies/news/176472/pressure-biosciences-names-damasio-as-finance-chief-as-it-travels-towards-profitability-176472.html Pressure BioSciences expands sales capabilities with new hires https://www.proactiveinvestors.com/companies/news/175312/pressure-biosciences-expands-sales-capabilities-with-new-hires-175312.html Thu, 23 Mar 2017 17:06:00 -0400 https://www.proactiveinvestors.com/companies/news/175312/pressure-biosciences-expands-sales-capabilities-with-new-hires-175312.html Pressure BioSciences sets stage for "very successful" 2017 https://www.proactiveinvestors.com/companies/news/175244/pressure-biosciences-sets-stage-for-very-successful-2017-175244.html Wed, 22 Mar 2017 18:15:00 -0400 https://www.proactiveinvestors.com/companies/news/175244/pressure-biosciences-sets-stage-for-very-successful-2017-175244.html Pressure BioSciences hits the CE Mark with next-gen sample preparation instrument https://www.proactiveinvestors.com/companies/news/172582/pressure-biosciences-hits-the-ce-mark-with-next-gen-sample-preparation-instrument-172582.html Thu, 02 Feb 2017 17:58:00 -0500 https://www.proactiveinvestors.com/companies/news/172582/pressure-biosciences-hits-the-ce-mark-with-next-gen-sample-preparation-instrument-172582.html Pressure BioSciences to present at RedChip's Global Online Growth Conference https://www.proactiveinvestors.com/companies/news/172134/pressure-biosciences-to-present-at-redchip-s-global-online-growth-conference-172134.html Tue, 24 Jan 2017 20:10:00 -0500 https://www.proactiveinvestors.com/companies/news/172134/pressure-biosciences-to-present-at-redchip-s-global-online-growth-conference-172134.html Pressure BioSciences to present at the 2017 Biotech Showcase https://www.proactiveinvestors.com/companies/news/171423/pressure-biosciences-to-present-at-the-2017-biotech-showcase-171423.html Tue, 10 Jan 2017 18:54:00 -0500 https://www.proactiveinvestors.com/companies/news/171423/pressure-biosciences-to-present-at-the-2017-biotech-showcase-171423.html Pressure BioSciences,’ big role in $1.8bn "Cancer Moonshot" initiative https://www.proactiveinvestors.com/companies/news/170622/pressure-biosciences-big-role-in-18bn-cancer-moonshot-initiative-170622.html Fri, 16 Dec 2016 19:18:00 -0500 https://www.proactiveinvestors.com/companies/news/170622/pressure-biosciences-big-role-in-18bn-cancer-moonshot-initiative-170622.html Pressure BioSciences hits record high quarterly product revenues https://www.proactiveinvestors.com/companies/news/169096/pressure-biosciences-hits-record-high-quarterly-product-revenues-169096.html Wed, 16 Nov 2016 19:34:00 -0500 https://www.proactiveinvestors.com/companies/news/169096/pressure-biosciences-hits-record-high-quarterly-product-revenues-169096.html Pressure BioSciences makes initial close in $2.5mln funding https://www.proactiveinvestors.com/companies/news/168956/pressure-biosciences-makes-initial-close-in-25mln-funding-168956.html Mon, 14 Nov 2016 19:49:00 -0500 https://www.proactiveinvestors.com/companies/news/168956/pressure-biosciences-makes-initial-close-in-25mln-funding-168956.html Pressure BioSciences, Inc. closes $2mln Line-of-Credit https://www.proactiveinvestors.com/companies/news/168505/pressure-biosciences-inc-closes-2mln-line-of-credit-168505.html Thu, 03 Nov 2016 20:55:00 -0400 https://www.proactiveinvestors.com/companies/news/168505/pressure-biosciences-inc-closes-2mln-line-of-credit-168505.html Pressure BioSciences' PCT platform features at major Australian cancer research centre https://www.proactiveinvestors.com/companies/news/168101/pressure-biosciences-pct-platform-features-at-major-australian-cancer-research-centre-168101.html Wed, 26 Oct 2016 18:48:00 -0400 https://www.proactiveinvestors.com/companies/news/168101/pressure-biosciences-pct-platform-features-at-major-australian-cancer-research-centre-168101.html Pressure BioSciences CEO to present at New York conference https://www.proactiveinvestors.com/companies/news/167504/pressure-biosciences-ceo-to-present-at-new-york-conference-167504.html Mon, 17 Oct 2016 12:28:00 -0400 https://www.proactiveinvestors.com/companies/news/167504/pressure-biosciences-ceo-to-present-at-new-york-conference-167504.html Pressure BioSciences strengthens in Q2, focuses on sales https://www.proactiveinvestors.com/companies/news/129393/pressure-biosciences-strengthens-in-q2-focuses-on-sales-129393.html Tue, 16 Aug 2016 19:28:00 -0400 https://www.proactiveinvestors.com/companies/news/129393/pressure-biosciences-strengthens-in-q2-focuses-on-sales-129393.html Pressure BioSciences announces initial shipments of its next-generation PCT System https://www.proactiveinvestors.com/companies/news/128491/pressure-biosciences-announces-initial-shipments-of-its-next-generation-pct-system-128491.html Thu, 21 Jul 2016 18:52:00 -0400 https://www.proactiveinvestors.com/companies/news/128491/pressure-biosciences-announces-initial-shipments-of-its-next-generation-pct-system-128491.html Pressure BioSciences unveils Barocycler 2320EXT at international conference https://www.proactiveinvestors.com/companies/news/128175/pressure-biosciences-unveils-barocycler-2320ext-at-international-conference-128175.html Wed, 13 Jul 2016 18:56:00 -0400 https://www.proactiveinvestors.com/companies/news/128175/pressure-biosciences-unveils-barocycler-2320ext-at-international-conference-128175.html Pressure Bioscience share price target raised https://www.proactiveinvestors.com/companies/news/275103/pressure-bioscience-share-price-target-raised-25103.html Thu, 26 May 2016 21:20:00 -0400 https://www.proactiveinvestors.com/companies/news/275103/pressure-bioscience-share-price-target-raised-25103.html Pressure Biosciences preps for up-list on US exchanges after Q1 earnings https://www.proactiveinvestors.com/companies/news/126118/pressure-biosciences-preps-for-up-list-on-us-exchanges-after-q1-earnings-126118.html Wed, 18 May 2016 18:52:00 -0400 https://www.proactiveinvestors.com/companies/news/126118/pressure-biosciences-preps-for-up-list-on-us-exchanges-after-q1-earnings-126118.html Pressure BioSciences to host teleconference to discuss results https://www.proactiveinvestors.com/companies/news/126054/pressure-biosciences-to-host-teleconference-to-discuss-results-126054.html Tue, 17 May 2016 19:54:00 -0400 https://www.proactiveinvestors.com/companies/news/126054/pressure-biosciences-to-host-teleconference-to-discuss-results-126054.html No pressure as Pressure BioSciences admitted to Richmond Club Index https://www.proactiveinvestors.com/companies/news/124719/no-pressure-as-pressure-biosciences-admitted-to-richmond-club-index-124719.html Tue, 12 Apr 2016 18:56:00 -0400 https://www.proactiveinvestors.com/companies/news/124719/no-pressure-as-pressure-biosciences-admitted-to-richmond-club-index-124719.html Pressure Biosciences share offering over-subscribed https://www.proactiveinvestors.com/companies/news/124588/pressure-biosciences-share-offering-over-subscribed-124588.html Fri, 08 Apr 2016 12:12:00 -0400 https://www.proactiveinvestors.com/companies/news/124588/pressure-biosciences-share-offering-over-subscribed-124588.html Pressure Biosciences Inc positioned for success in 2016 https://www.proactiveinvestors.com/companies/news/124561/pressure-biosciences-inc-positioned-for-success-in-2016-124561.html Thu, 07 Apr 2016 15:45:00 -0400 https://www.proactiveinvestors.com/companies/news/124561/pressure-biosciences-inc-positioned-for-success-in-2016-124561.html Pressure BioSciences Inc looks ahead to technology showcase at Boston proteome conference https://www.proactiveinvestors.com/companies/news/123641/pressure-biosciences-inc-looks-ahead-to-technology-showcase-at-boston-proteome-conference-123641.html Mon, 14 Mar 2016 13:56:00 -0400 https://www.proactiveinvestors.com/companies/news/123641/pressure-biosciences-inc-looks-ahead-to-technology-showcase-at-boston-proteome-conference-123641.html Pressure BioSciences closes first tranche of offer https://www.proactiveinvestors.com/companies/news/123174/pressure-biosciences-closes-first-tranche-of-offer-123174.html Tue, 01 Mar 2016 17:26:00 -0500 https://www.proactiveinvestors.com/companies/news/123174/pressure-biosciences-closes-first-tranche-of-offer-123174.html Pressure Bioscience ready for next level, says chief https://www.proactiveinvestors.com/companies/news/121947/pressure-bioscience-ready-for-next-level-says-chief-121947.html Fri, 29 Jan 2016 14:20:00 -0500 https://www.proactiveinvestors.com/companies/news/121947/pressure-bioscience-ready-for-next-level-says-chief-121947.html Pressure Bioscience inks co-marketing deal with SCIEX https://www.proactiveinvestors.com/companies/news/121223/pressure-bioscience-inks-co-marketing-deal-with-sciex-121223.html Tue, 12 Jan 2016 17:00:00 -0500 https://www.proactiveinvestors.com/companies/news/121223/pressure-bioscience-inks-co-marketing-deal-with-sciex-121223.html PressureBioSciences upbeat after fund-raising tops expectations https://www.proactiveinvestors.com/companies/news/121189/pressurebiosciences-upbeat-after-fund-raising-tops-expectations-121189.html Mon, 11 Jan 2016 18:10:00 -0500 https://www.proactiveinvestors.com/companies/news/121189/pressurebiosciences-upbeat-after-fund-raising-tops-expectations-121189.html Pressure BioSciences pays off its convertible variable debt https://www.proactiveinvestors.com/companies/news/120495/pressure-biosciences-pays-off-its-convertible-variable-debt-120495.html Tue, 15 Dec 2015 15:23:00 -0500 https://www.proactiveinvestors.com/companies/news/120495/pressure-biosciences-pays-off-its-convertible-variable-debt-120495.html SeeThruEquity says Pressure BioSciences on pace to match 2015 guidance https://www.proactiveinvestors.com/companies/news/119460/seethruequity-says-pressure-biosciences-on-pace-to-match-2015-guidance-119460.html Thu, 19 Nov 2015 18:35:00 -0500 https://www.proactiveinvestors.com/companies/news/119460/seethruequity-says-pressure-biosciences-on-pace-to-match-2015-guidance-119460.html Analysts upbeat on Pressure BioSciences https://www.proactiveinvestors.com/companies/news/119333/analysts-upbeat-on-pressure-biosciences-119333.html Tue, 17 Nov 2015 21:05:00 -0500 https://www.proactiveinvestors.com/companies/news/119333/analysts-upbeat-on-pressure-biosciences-119333.html Pressure Biosciences brings in US$4mln from private placing https://www.proactiveinvestors.com/companies/news/119329/pressure-biosciences-brings-in-us4mln-from-private-placing-119329.html Tue, 17 Nov 2015 17:44:00 -0500 https://www.proactiveinvestors.com/companies/news/119329/pressure-biosciences-brings-in-us4mln-from-private-placing-119329.html Pressure Biosciences at major inflection point as revenues surge https://www.proactiveinvestors.com/companies/news/119131/pressure-biosciences-at-major-inflection-point-as-revenues-surge-119131.html Thu, 12 Nov 2015 20:14:00 -0500 https://www.proactiveinvestors.com/companies/news/119131/pressure-biosciences-at-major-inflection-point-as-revenues-surge-119131.html Pressure BioSciences to work with university on "next generation" rape case kit https://www.proactiveinvestors.com/companies/news/116322/pressure-biosciences-to-work-with-university-on-next-generation-rape-case-kit-116322.html Fri, 16 Oct 2015 16:02:00 -0400 https://www.proactiveinvestors.com/companies/news/116322/pressure-biosciences-to-work-with-university-on-next-generation-rape-case-kit-116322.html Pressure BioSciences receives another chunk of money from placement https://www.proactiveinvestors.com/companies/news/111207/pressure-biosciences-receives-another-chunk-of-money-from-placement-111207.html Mon, 28 Sep 2015 19:56:00 -0400 https://www.proactiveinvestors.com/companies/news/111207/pressure-biosciences-receives-another-chunk-of-money-from-placement-111207.html Pressure BioSciences unveils collaboration with India’s IOB; shares rise https://www.proactiveinvestors.com/companies/news/110321/pressure-biosciences-unveils-collaboration-with-indias-iob-shares-rise-110321.html Wed, 26 Aug 2015 19:18:00 -0400 https://www.proactiveinvestors.com/companies/news/110321/pressure-biosciences-unveils-collaboration-with-indias-iob-shares-rise-110321.html Pressure BioSciences unveils 2-yr collaboration with India’s IOB; shares rise https://www.proactiveinvestors.com/companies/news/115265/pressure-biosciences-unveils-2-yr-collaboration-with-indias-iob-shares-rise-115265.html Wed, 26 Aug 2015 17:34:00 -0400 https://www.proactiveinvestors.com/companies/news/115265/pressure-biosciences-unveils-2-yr-collaboration-with-indias-iob-shares-rise-115265.html Pressure Biosciences' top line momentum continues https://www.proactiveinvestors.com/companies/news/110028/pressure-biosciences-top-line-momentum-continues-110028.html Mon, 17 Aug 2015 20:57:00 -0400 https://www.proactiveinvestors.com/companies/news/110028/pressure-biosciences-top-line-momentum-continues-110028.html Pressure BioSciences has Polish small cap specialist in its corner https://www.proactiveinvestors.com/companies/news/109992/pressure-biosciences-has-polish-small-cap-specialist-in-its-corner-109992.html Fri, 14 Aug 2015 19:57:00 -0400 https://www.proactiveinvestors.com/companies/news/109992/pressure-biosciences-has-polish-small-cap-specialist-in-its-corner-109992.html Pressure BioSciences closes US$2 million in proceeds from financing to grow and pay down debt https://www.proactiveinvestors.com/companies/news/115264/pressure-biosciences-closes-us2-million-in-proceeds-from-financing-to-grow-and-pay-down-debt-115264.html Fri, 24 Jul 2015 17:44:00 -0400 https://www.proactiveinvestors.com/companies/news/115264/pressure-biosciences-closes-us2-million-in-proceeds-from-financing-to-grow-and-pay-down-debt-115264.html Chinese and Swiss researchers see Pressure BioSciences’ PCT platform as essential in improving clinical management of diabetes https://www.proactiveinvestors.com/companies/news/115263/chinese-and-swiss-researchers-see-pressure-biosciences-pct-platform-as-essential-in-improving-clinical-management-of-diabetes-115263.html Mon, 13 Jul 2015 21:56:00 -0400 https://www.proactiveinvestors.com/companies/news/115263/chinese-and-swiss-researchers-see-pressure-biosciences-pct-platform-as-essential-in-improving-clinical-management-of-diabetes-115263.html Chinese and Swiss researchers see Pressure BioSciences’ PCT platform as essential in improving clini https://www.proactiveinvestors.com/companies/news/108948/chinese-and-swiss-researchers-see-pressure-biosciences-pct-platform-as-essential-in-improving-clini-108948.html Mon, 13 Jul 2015 21:31:00 -0400 https://www.proactiveinvestors.com/companies/news/108948/chinese-and-swiss-researchers-see-pressure-biosciences-pct-platform-as-essential-in-improving-clini-108948.html Pressure BioSciences’ PCT Platform for extracting DNA from forensic samples shows promising results https://www.proactiveinvestors.com/companies/news/108812/pressure-biosciences-pct-platform-for-extracting-dna-from-forensic-samples-shows-promising-results-108812.html Wed, 08 Jul 2015 20:49:00 -0400 https://www.proactiveinvestors.com/companies/news/108812/pressure-biosciences-pct-platform-for-extracting-dna-from-forensic-samples-shows-promising-results-108812.html Three independent studies show growing support for Pressure BioSciences’ PCT Platform https://www.proactiveinvestors.com/companies/news/106509/three-independent-studies-show-growing-support-for-pressure-biosciences-pct-platform-61310.html The scientists showed that high pressure is emerging as a powerful tool for understanding protein structure and function delivering direct evidence of the different ways proteins can respond to pressure. The study hinted that the way proteins respond to pressure could change the way drugs are designed and developed.

]]>
Mon, 04 May 2015 18:36:00 -0400 https://www.proactiveinvestors.com/companies/news/106509/three-independent-studies-show-growing-support-for-pressure-biosciences-pct-platform-61310.html
NU scientists adopt Pressure BioSciences’ HT48 system to detect fetal exposure to tobacco https://www.proactiveinvestors.com/companies/news/106506/nu-scientists-adopt-pressure-biosciences-ht48-system-to-detect-fetal-exposure-to-tobacco-61306.html The Funk Laboratory focuses on developing and applying biomarker methods to explore environmental risk factors tied to chronic diseases, cancers and other disorders. It is currently an existing customer of PBIO’s pressure cycling technology (PCT) instruments and products

]]>
Fri, 01 May 2015 16:16:00 -0400 https://www.proactiveinvestors.com/companies/news/106506/nu-scientists-adopt-pressure-biosciences-ht48-system-to-detect-fetal-exposure-to-tobacco-61306.html
Pressure BioSciences' price target increased by 560 percent https://www.proactiveinvestors.com/companies/news/106211/pressure-biosciences-price-target-increased-by-560-percent-61132.html Ajay Tandon, SeeThruEquity’s CEO, downplayed the overall 2014 year-to-year revenue, noting that it is almost irrelevant given growth in PBIO’s core products and services as well as the completion of important product improvements that suggest 2015E revenue to reach US$2.5 million, 81.9 percent higher YoY

]]>
Thu, 23 Apr 2015 15:50:00 -0400 https://www.proactiveinvestors.com/companies/news/106211/pressure-biosciences-price-target-increased-by-560-percent-61132.html
Pressure BioSciences ramps up growth, with record 2014 product sales https://www.proactiveinvestors.com/companies/news/106210/pressure-biosciences-ramps-up-growth-with-record-2014-product-sales-60828.html Pressure BioSciences (OTCQB:PBIO) was upgraded Thursday by analysts at Zacks Research, which continues to be bullish on the life sciences company's shares after it reported record revenue for 2014, with expectations for continued sales growth in 2015 and beyond.

]]>
Thu, 02 Apr 2015 18:04:00 -0400 https://www.proactiveinvestors.com/companies/news/106210/pressure-biosciences-ramps-up-growth-with-record-2014-product-sales-60828.html
Pressure BioSciences unveils new, faster sample preparation system for proteins https://www.proactiveinvestors.com/companies/news/105882/pressure-biosciences-unveils-new-faster-sample-preparation-system-for-proteins-60385.html Pressure BioSciences (OTCQB:PBIO) has launched a new major sample preparation system for proteins known as PCT-HD, which is based on the company's renowned pressure cycling technology (PCT) for the life sciences industry. 

]]>
Thu, 12 Mar 2015 17:39:00 -0400 https://www.proactiveinvestors.com/companies/news/105882/pressure-biosciences-unveils-new-faster-sample-preparation-system-for-proteins-60385.html
Pressure BioSciences sees 2015 as year of substantial growth https://www.proactiveinvestors.com/companies/news/105630/pressure-biosciences-sees-2015-as-year-of-substantial-growth-60041.html Pressure BioSciences (OTCMKTS:PBIO) is in for a terrific year, according to chief executive officer Richard Schumacher, who spoke in a recent video interview with StockNewsNow.com which was published today.

]]>
Tue, 24 Feb 2015 15:29:00 -0500 https://www.proactiveinvestors.com/companies/news/105630/pressure-biosciences-sees-2015-as-year-of-substantial-growth-60041.html
Pressure BioSciences receives $1 mln grant from NIH to develop sample preparation platform for NGS system https://www.proactiveinvestors.com/companies/news/105574/pressure-biosciences-receives-1-mln-grant-from-nih-to-develop-sample-preparation-platform-for-ngs-system-59969.html Pressure BioSciences (OTCQB:PBIO) has been awarded an over $1 million, phase II grant from the National Institutes of Health (NIH), which will help fund the development of an automated, high throughput, high pressure system to better control DNA fragmentation, the company said.

]]>
Thu, 19 Feb 2015 17:44:00 -0500 https://www.proactiveinvestors.com/companies/news/105574/pressure-biosciences-receives-1-mln-grant-from-nih-to-develop-sample-preparation-platform-for-ngs-system-59969.html
Pressure BioSciences raises $1.17 mln, to bolster sales efforts https://www.proactiveinvestors.com/companies/news/105232/pressure-biosciences-raises-117-mln-to-bolster-sales-efforts-59495.html Wed, 21 Jan 2015 15:19:00 -0500 https://www.proactiveinvestors.com/companies/news/105232/pressure-biosciences-raises-117-mln-to-bolster-sales-efforts-59495.html Pressure BioSciences ships third new Barozyme system to top-ranked U.S. medical school https://www.proactiveinvestors.com/companies/news/104625/pressure-biosciences-ships-third-new-barozyme-system-to-top-ranked-us-medical-school-58717.html Pressure BioSciences (OTCQB:PBIO) has shipped its third new Barozyme high throughput HT48 system to the Funk Laboratory of the Feinberg School of Medicine at Northwestern, the company said Wednesday.

]]>
Wed, 10 Dec 2014 17:19:00 -0500 https://www.proactiveinvestors.com/companies/news/104625/pressure-biosciences-ships-third-new-barozyme-system-to-top-ranked-us-medical-school-58717.html
Pressure BioSciences installs first 2 Barozyme high throughput systems, expects to ship next 3 in the coming weeks https://www.proactiveinvestors.com/companies/news/104258/pressure-biosciences-installs-first-2-barozyme-high-throughput-systems-expects-to-ship-next-3-in-the-coming-weeks-58221.html Pressure BioSciences (OTCQB:PBIO) says it has installed its first two Barozyme HT-48 high throughput systems for independent evaluation and potential sale.

]]>
Tue, 18 Nov 2014 15:23:00 -0500 https://www.proactiveinvestors.com/companies/news/104258/pressure-biosciences-installs-first-2-barozyme-high-throughput-systems-expects-to-ship-next-3-in-the-coming-weeks-58221.html
Pressure BioSciences posts 14% rise in Q3 products and services revenue, growth expected to continue https://www.proactiveinvestors.com/companies/news/104241/pressure-biosciences-posts-14-rise-in-q3-products-and-services-revenue-growth-expected-to-continue-58199.html Pressure BioSciences (OTCQB:PBIO) said it continued to trim its operating loss as products and services revenue climbed 14 percent in the third quarter.

]]>
Mon, 17 Nov 2014 18:13:00 -0500 https://www.proactiveinvestors.com/companies/news/104241/pressure-biosciences-posts-14-rise-in-q3-products-and-services-revenue-growth-expected-to-continue-58199.html
Pressure BioSciences climbs 11% on new method to analyze small needle biopsy samples https://www.proactiveinvestors.com/companies/news/103845/pressure-biosciences-climbs-11-on-new-method-to-analyze-small-needle-biopsy-samples-57678.html Pressure BioSciences' (OTCQB:PBIO) pressure cycling technology (PCT) has been used to develop a method to analyze thousands of proteins by mass spectrometry on small, needle biopsy samples for the first time, according to a presentation at the Human Proteome Organization World Congress in Spain held earlier this month.

]]>
Mon, 27 Oct 2014 18:22:00 -0400 https://www.proactiveinvestors.com/companies/news/103845/pressure-biosciences-climbs-11-on-new-method-to-analyze-small-needle-biopsy-samples-57678.html
Pressure BioSciences agrees to exclusive 3-yr distribution deal with China's Powertech https://www.proactiveinvestors.com/companies/news/103738/pressure-biosciences-agrees-to-exclusive-3-yr-distribution-deal-with-chinas-powertech--57529.html Pressure BioSciences (OTCQB:PBIO) has expanded the reach of its products with a three-year exclusive distribution agreement with China's Powertech Technology, the company said Monday.

]]>
Mon, 20 Oct 2014 17:33:00 -0400 https://www.proactiveinvestors.com/companies/news/103738/pressure-biosciences-agrees-to-exclusive-3-yr-distribution-deal-with-chinas-powertech--57529.html
Pressure BioSciences now expects sales from new Barozyme device this year https://www.proactiveinvestors.com/companies/news/103335/pressure-biosciences-now-expects-sales-from-new-barozyme-device-this-year-56932.html Pressure BioSciences (OTCQB:PBIO) says it has completed the first phase of its commercialization plan for its new high throughput PCT-based Barozyme HT48 system, with the first instrument scheduled to be ready for shipment by mid-October.

]]>
Fri, 19 Sep 2014 15:38:00 -0400 https://www.proactiveinvestors.com/companies/news/103335/pressure-biosciences-now-expects-sales-from-new-barozyme-device-this-year-56932.html
Pressure BioSciences posts 56% climb in Q2 products and services revenue, more growth anticipated https://www.proactiveinvestors.com/companies/news/102820/pressure-biosciences-posts-56-climb-in-q2-products-and-services-revenue-more-growth-anticipated-56168.html The life sciences company, which recently launched its high throughput PCT-based instrument in June, said revenue from the sale of products and services climbed to $307,464 for the three months to June 30, compared to $196,522 in the corresponding period of 2013.

]]>
Thu, 14 Aug 2014 18:42:00 -0400 https://www.proactiveinvestors.com/companies/news/102820/pressure-biosciences-posts-56-climb-in-q2-products-and-services-revenue-more-growth-anticipated-56168.html
Pressure BioSciences hires advisor for strategic review https://www.proactiveinvestors.com/companies/news/102027/pressure-biosciences-hires-advisor-for-strategic-review-55055.html Thu, 26 Jun 2014 17:39:00 -0400 https://www.proactiveinvestors.com/companies/news/102027/pressure-biosciences-hires-advisor-for-strategic-review-55055.html Pressure BioSciences strongly expects to secure marketing/sales partnership by year-end https://www.proactiveinvestors.com/companies/news/101950/pressure-biosciences-strongly-expects-to-secure-marketingsales-partnership-by-year-end-54942.html Pressure BioSciences (OTCQB:PBIO) reassured investors that it expects to secure at least one strategic marketing or sales partner before the end of the year after the successful launch of its high throughput PCT-based system last week.

]]>
Mon, 23 Jun 2014 18:18:00 -0400 https://www.proactiveinvestors.com/companies/news/101950/pressure-biosciences-strongly-expects-to-secure-marketingsales-partnership-by-year-end-54942.html
Pressure BioSciences has success at annual Mass Spectrometry conference https://www.proactiveinvestors.com/companies/news/101907/pressure-biosciences-has-success-at-annual-mass-spectrometry-conference-54881.html Pressure BioSciences' (OTCQB: PBIO) pressure cycling technology has proven rather useful in the field of biological sample preparation, after six separate research groups recently presented data that showed the use of PCT led to better quality test results while improving time or cost efficiency.

]]>
Thu, 19 Jun 2014 18:07:00 -0400 https://www.proactiveinvestors.com/companies/news/101907/pressure-biosciences-has-success-at-annual-mass-spectrometry-conference-54881.html
Pressure BioSciences expects upcoming launch of new instrument to increase PCT platform adoption https://www.proactiveinvestors.com/companies/news/101815/pressure-biosciences-expects-upcoming-launch-of-new-instrument-to-increase-pct-platform-adoption-54761.html Pressure BioSciences (OTCQB:PBIO) is launching its long awaited high throughput barocycler at the upcoming American Society for Mass Spectrometry annual conference this week in Baltimore. 

]]>
Mon, 16 Jun 2014 12:39:00 -0400 https://www.proactiveinvestors.com/companies/news/101815/pressure-biosciences-expects-upcoming-launch-of-new-instrument-to-increase-pct-platform-adoption-54761.html
Pressure BioSciences' Q1 results an indication of continued strong growth https://www.proactiveinvestors.com/companies/news/101361/pressure-biosciences-q1-results-an-indication-of-continued-strong-growth--54156.html Life sciences company Pressure BioSciences (OTCQB: PBIO) delivered Thursday the results of a strong first quarter, including sales of consumables that more than doubled. 

]]>
Thu, 15 May 2014 17:59:00 -0400 https://www.proactiveinvestors.com/companies/news/101361/pressure-biosciences-q1-results-an-indication-of-continued-strong-growth--54156.html
Pressure BioSciences takes the stage at Cavendish Global Health Impact Forum at UN headquarters; stock jumps https://www.proactiveinvestors.com/companies/news/101152/pressure-biosciences-takes-the-stage-at-cavendish-global-health-impact-forum-at-un-headquarters-stock-jumps-53875.html Pressure BioSciences (OTCQB: PBIO) surged over 20% this morning after the life sciences company announced it has been chosen to present at the Cavendish Global Health Impact Forum beginning today at the UN headquarters in New York. 

]]>
Mon, 05 May 2014 15:13:00 -0400 https://www.proactiveinvestors.com/companies/news/101152/pressure-biosciences-takes-the-stage-at-cavendish-global-health-impact-forum-at-un-headquarters-stock-jumps-53875.html
Pressure BioSciences impresses, price target hiked 60%: Zacks Small Cap Research https://www.proactiveinvestors.com/companies/news/100657/pressure-biosciences-impresses-price-target-hiked-60-zacks-small-cap-research-53197.html Pressure BioSciences (OTCMKTS:PBIO) has received a vote of confidence from analyst Grant Zeng at Zacks Small Cap Research, who bumped up his 12-month price target on the company by 60%, citing strong fourth quarter and fiscal year 2013 results, improving business development strategies and a "very attractive valuation". 

]]>
Thu, 03 Apr 2014 17:02:00 -0400 https://www.proactiveinvestors.com/companies/news/100657/pressure-biosciences-impresses-price-target-hiked-60-zacks-small-cap-research-53197.html
Pressure BioSciences finishes successful year on strong note as revenues rise 64% https://www.proactiveinvestors.com/companies/news/100616/pressure-biosciences-finishes-successful-year-on-strong-note-as-revenues-rise-64-53137.html The quarter was a strong finish to what chief executive Richard Schumacher referred to as a year of successes for the company following four straight quarters of year-over-year revenue growth and a technological breakthrough with its core platform. 

]]>
Tue, 01 Apr 2014 18:05:00 -0400 https://www.proactiveinvestors.com/companies/news/100616/pressure-biosciences-finishes-successful-year-on-strong-note-as-revenues-rise-64-53137.html
Pressure BioSciences soars on launch of ultra high pressure instrument system set to make waves in biotech industry https://www.proactiveinvestors.com/companies/news/100410/pressure-biosciences-soars-on-launch-of-ultra-high-pressure-instrument-system-set-to-make-waves-in-biotech-industry-52859.html Pressure BioSciences said that it believes its new product will be the instrument of choice for a broad range of studies that can use the special effects of ultra-high pressure on biological samples, with the instrument capable of reaching pressure levels well beyond any automated bench-top pressure instrument on the market today.

]]>
Wed, 19 Mar 2014 15:58:00 -0400 https://www.proactiveinvestors.com/companies/news/100410/pressure-biosciences-soars-on-launch-of-ultra-high-pressure-instrument-system-set-to-make-waves-in-biotech-industry-52859.html
Pressure BioSciences: "a biotech dark horse", says Seeking Alpha contributor https://www.proactiveinvestors.com/companies/news/100278/pressure-biosciences-a-biotech-dark-horse-says-seeking-alpha-contributor-52680.html Shares of Pressure BioSciences (OTC:PBIO) were rising on Tuesday on the back of a Seeking Alpha article that named the life sciences company among one of three chosen biotech plays the influential financial markets blog recommends investors shouldn't disregard in 2014.

]]>
Tue, 11 Mar 2014 17:35:00 -0400 https://www.proactiveinvestors.com/companies/news/100278/pressure-biosciences-a-biotech-dark-horse-says-seeking-alpha-contributor-52680.html
Pressure BioSciences bolsters financing again to $3.5 mln, closes third tranche https://www.proactiveinvestors.com/companies/news/100229/pressure-biosciences-bolsters-financing-again-to-35-mln-closes-third-tranche-52604.html Pressure BioSciences (OTC:PBIO) has closed a third tranche of its financing that has so far raised well over its initial goal, and has approved plans to extend the offering once again to bump up the total anticipated proceeds to $3.5 million. 

]]>
Fri, 07 Mar 2014 15:52:00 -0500 https://www.proactiveinvestors.com/companies/news/100229/pressure-biosciences-bolsters-financing-again-to-35-mln-closes-third-tranche-52604.html
Pressure BioSciences amidst "a critical transition year", with cash on the books: Merriman Capital https://www.proactiveinvestors.com/companies/news/99996/pressure-biosciences-amidst-a-critical-transition-year-with-cash-on-the-books-merriman-capital-52234.html Pressure BioSciences (OTCMKTS:PBIO), which is developing its pressure cycling technology (PCT), had its buy rating and $1.05 price target maintained Friday by Merriman Capital analyst Andrew D'Silva, who said that the life science's company recent fundraising efforts have paid off and are expected to sustain operations until the end of the fiscal year, with critical transition, rapid revenue growth and share price appreciation all in the cards. 

]]>
Fri, 21 Feb 2014 14:22:00 -0500 https://www.proactiveinvestors.com/companies/news/99996/pressure-biosciences-amidst-a-critical-transition-year-with-cash-on-the-books-merriman-capital-52234.html
Pressure BioSciences closes second tranche of financing well over initial goal https://www.proactiveinvestors.com/companies/news/99738/pressure-biosciences-closes-second-tranche-of-financing-well-over-initial-goal-51838.html Pressure BioSciences (OTC:PBIO), which is developing its pressure cycling technology (PCT) for the sample preparation market, has just closed the second tranche of a private placement financing initially disclosed by the company in December, raising $1.2 million and far surpassing the original $0.5 million goal. 

]]>
Wed, 05 Feb 2014 15:09:00 -0500 https://www.proactiveinvestors.com/companies/news/99738/pressure-biosciences-closes-second-tranche-of-financing-well-over-initial-goal-51838.html
Pressure BioSciences: "patient investors will get rewarded", says Zacks https://www.proactiveinvestors.com/companies/news/99585/pressure-biosciences-patient-investors-will-get-rewarded-says-zacks-51566.html Pressure BioSciences (OTCMKTS:PBIO) currently has a "very attractive" valuation, according to Zacks Investment Research, which views the life sciences company's platform pressure cycling technology (PCT) as impressive, citing competitive advantages over existing technologies in the sample preparation market. 

]]>
Mon, 27 Jan 2014 17:48:00 -0500 https://www.proactiveinvestors.com/companies/news/99585/pressure-biosciences-patient-investors-will-get-rewarded-says-zacks-51566.html
Pressure BioSciences expected to see profits in 2015, says AMI Research https://www.proactiveinvestors.com/companies/news/99549/pressure-biosciences-expected-to-see-profits-in-2015-says-ami-research-51503.html Pressure BioSciences (OTC:PBIO) is expected to become profitable in 2015, according to a report written this month from AMI Research, which chose the company as one of its five favourite stock names in the micro cap sector that offer the "most promise for growth in 2014". 

]]>
Thu, 23 Jan 2014 17:08:00 -0500 https://www.proactiveinvestors.com/companies/news/99549/pressure-biosciences-expected-to-see-profits-in-2015-says-ami-research-51503.html
Pressure BioSciences gets 50% increase in price target from Merriman Capital https://www.proactiveinvestors.com/companies/news/98935/pressure-biosciences-gets-50-increase-in-price-target-from-merriman-capital-50556.html Pressure BioSciences (OTCMKTS:PBIO) had its speculative buy rating maintained and price target increased by Merriman Capital Monday, on the back of strong growth in third quarter revenue. 

]]>
Mon, 09 Dec 2013 15:26:00 -0500 https://www.proactiveinvestors.com/companies/news/98935/pressure-biosciences-gets-50-increase-in-price-target-from-merriman-capital-50556.html
Pressure BioSciences sees materially improved financials ahead https://www.proactiveinvestors.com/companies/news/98548/pressure-biosciences-sees-materially-improved-financials-ahead-49958.html Pressure BioSciences (OTCQB:PBIO) says it believes its financial situation by the end of this year will be significantly better than it has in years past as revenue continues to climb for its products and as it plans to repay all convertible debt outstanding. 

]]>
Mon, 18 Nov 2013 18:59:00 -0500 https://www.proactiveinvestors.com/companies/news/98548/pressure-biosciences-sees-materially-improved-financials-ahead-49958.html
Pressure BioSciences sees ramping revenue trend continuing https://www.proactiveinvestors.com/companies/news/98381/pressure-biosciences-sees-ramping-revenue-trend-continuing-49712.html Pressure BioSciences (OTCQB:PBIO) has reported a record-breaking quarter, with every expectation that solid revenue growth will continue into next year. 

]]>
Fri, 08 Nov 2013 17:49:00 -0500 https://www.proactiveinvestors.com/companies/news/98381/pressure-biosciences-sees-ramping-revenue-trend-continuing-49712.html
Pressure BioSciences soars as Merriman Capital gives thumbs up, seeing accelerating growth ahead https://www.proactiveinvestors.com/companies/news/96764/pressure-biosciences-soars-as-merriman-capital-gives-thumbs-up-seeing-accelerating-growth-ahead-46962.html Shares of Pressure BioSciences (OTCQB:PBIO) surged on Thursday after the company received a 12-month price target from Merriman Capital analyst Paul Resnik that was almost three times its current market valuation at the time the report, released today, was written. 

]]>
Thu, 08 Aug 2013 18:08:00 -0400 https://www.proactiveinvestors.com/companies/news/96764/pressure-biosciences-soars-as-merriman-capital-gives-thumbs-up-seeing-accelerating-growth-ahead-46962.html
Pressure BioSciences says additional data presented showing PCT platform gives new insights for potential biomarker discovery tool https://www.proactiveinvestors.com/companies/news/96641/pressure-biosciences-says-additional-data-presented-showing-pct-platform-gives-new-insights-for-potential-biomarker-discovery-tool-46726.html Thu, 01 Aug 2013 15:49:00 -0400 https://www.proactiveinvestors.com/companies/news/96641/pressure-biosciences-says-additional-data-presented-showing-pct-platform-gives-new-insights-for-potential-biomarker-discovery-tool-46726.html Pressure BioSciences slightly surpasses $2 mln financing goal https://www.proactiveinvestors.com/companies/news/95640/pressure-biosciences-slightly-surpasses-2-mln-financing-goal-45042.html Fri, 14 Jun 2013 18:59:00 -0400 https://www.proactiveinvestors.com/companies/news/95640/pressure-biosciences-slightly-surpasses-2-mln-financing-goal-45042.html Pressure BioSciences says new high throughput design for platform technology expected to accelerate growth https://www.proactiveinvestors.com/companies/news/95390/pressure-biosciences-says-new-high-throughput-design-for-platform-technology-expected-to-accelerate-growth-44636.html Pressure BioSciences (OTCQB:PBIO) says it has a new high throughput (HT) design for its patented pressure cycling technology (PCT) that will integrate its platform with the automated HT sample preparation and analytical system formats installed in thousands of research labs globally. 

]]>
Tue, 04 Jun 2013 17:17:00 -0400 https://www.proactiveinvestors.com/companies/news/95390/pressure-biosciences-says-new-high-throughput-design-for-platform-technology-expected-to-accelerate-growth-44636.html
Pressure BioSciences draws attention with breakthrough announcement https://www.proactiveinvestors.com/companies/news/95238/pressure-biosciences-draws-attention-with-breakthrough-announcement-44352.html Pressure BioSciences (OTCQB:PBIO) has been generating some buzz as of late, recently  featured in two different investment articles listing stocks to watch in the life sciences space. 

]]>
Tue, 28 May 2013 19:22:00 -0400 https://www.proactiveinvestors.com/companies/news/95238/pressure-biosciences-draws-attention-with-breakthrough-announcement-44352.html
Pressure BioSciences rallies on potential new method for screening GI system using core PCT technology https://www.proactiveinvestors.com/companies/news/95019/pressure-biosciences-rallies-on-potential-new-method-for-screening-gi-system-using-core-pct-technology-43978.html Pressure BioSciences, (OTCQB: PBIO), a company focused on developing its pressure cycling technology (PCT), says that researchers at Harvard Medical School have published a scientific paper describing a non-invasive method that could potentially screen for multiple diseases by gaining information about the gastrointestinal (GI) system using PCT and certain chemicals. 

]]>
Thu, 16 May 2013 17:56:00 -0400 https://www.proactiveinvestors.com/companies/news/95019/pressure-biosciences-rallies-on-potential-new-method-for-screening-gi-system-using-core-pct-technology-43978.html
Pressure BioSciences 2013 revenue expected to grow 37%, says AMI Research https://www.proactiveinvestors.com/companies/news/94395/pressure-biosciences-2013-revenue-expected-to-grow-37-says-ami-research-42910.html The research firm said it expects the company to be profitable in 2014 as it increases its market share. The company "is poised for substantial growth with the aggressive commercialization and increased distributor agreements, of its Barocycler product portfolio, new offerings in its pipeline and promising new markets for its existing technology."

]]>
Thu, 18 Apr 2013 18:49:00 -0400 https://www.proactiveinvestors.com/companies/news/94395/pressure-biosciences-2013-revenue-expected-to-grow-37-says-ami-research-42910.html
Pressure BioSciences deeply undervalued, says analyst; "huge opportunities" ahead https://www.proactiveinvestors.com/companies/news/94083/pressure-biosciences-deeply-undervalued-says-analyst-huge-opportunities-ahead-42383.html Shares of Pressure BioSciences (OTCQB:PBIO), a life sciences company focused on developing its pressure cycling technology (PCT), have been described as "deeply undervalued", according to Zacks Investment Research analyst Grant Zeng, when looking at the company's fundamentals.

]]>
Fri, 05 Apr 2013 13:42:00 -0400 https://www.proactiveinvestors.com/companies/news/94083/pressure-biosciences-deeply-undervalued-says-analyst-huge-opportunities-ahead-42383.html
Pressure BioSciences reports progress in PCT-based rape kit testing https://www.proactiveinvestors.com/companies/news/94068/pressure-biosciences-reports-progress-in-pct-based-rape-kit-testing-42345.html Thu, 04 Apr 2013 17:19:00 -0400 https://www.proactiveinvestors.com/companies/news/94068/pressure-biosciences-reports-progress-in-pct-based-rape-kit-testing-42345.html Pressure BioSciences says new PCT-based apps featured at a conference; to impact 2013 sales https://www.proactiveinvestors.com/companies/news/93727/pressure-biosciences-says-new-pct-based-apps-featured-at-a-conference-to-impact-2013-sales--41797.html Pressure BioSciences (OTCQB:PBIO), a life science company developing pressure cycling technology, or PCT, said that recent research has shown that PCT-based sample preparation methods have yielded improved quality and efficiency of test results.

]]>
Tue, 19 Mar 2013 20:20:00 -0400 https://www.proactiveinvestors.com/companies/news/93727/pressure-biosciences-says-new-pct-based-apps-featured-at-a-conference-to-impact-2013-sales--41797.html
Pressure BioSciences bolsters board of directors with addition of Dr. Mickey Urdea https://www.proactiveinvestors.com/companies/news/92994/pressure-biosciences-bolsters-board-of-directors-with-addition-of-dr-mickey-urdea-40502.html Pressure BioSciences (OTCQB:PBIO) says it has appointed Dr. Mickey Urdea to its board of directors, filling the vacancy of Wayne Fritzsche, who resigned last week to pursue a full-time management position with the company as it builds out commercially. 

]]>
Tue, 12 Feb 2013 15:10:00 -0500 https://www.proactiveinvestors.com/companies/news/92994/pressure-biosciences-bolsters-board-of-directors-with-addition-of-dr-mickey-urdea-40502.html
Pressure BioSciences sees stock rally as commercialization progress continues https://www.proactiveinvestors.com/companies/news/92750/pressure-biosciences-sees-stock-rally-as-commercialization-progress-continues-40041.html Pressure BioSciences (OTC:PBIO) shares have risen more than 77% in the past three months as the company made a series of advancements last year, with investors expecting more good news in 2013. 

 

]]>
Wed, 30 Jan 2013 17:59:00 -0500 https://www.proactiveinvestors.com/companies/news/92750/pressure-biosciences-sees-stock-rally-as-commercialization-progress-continues-40041.html
Pressure BioSciences' platform could help end "national travesty" as bill to end rape kit backlog introduced in Congress https://www.proactiveinvestors.com/companies/news/91854/pressure-biosciences-platform-could-help-end-national-travesty-as-bill-to-end-rape-kit-backlog-introduced-in-congress-38481.html Tue, 11 Dec 2012 15:37:00 -0500 https://www.proactiveinvestors.com/companies/news/91854/pressure-biosciences-platform-could-help-end-national-travesty-as-bill-to-end-rape-kit-backlog-introduced-in-congress-38481.html Pressure BioSciences upgraded to "outperform" by Zacks as PCT platform increasingly gains recognition https://www.proactiveinvestors.com/companies/news/91589/pressure-biosciences-upgraded-to-outperform-by-zacks-as-pct-platform-increasingly-gains-recognition-37966.html Pressure BioSciences (OTCQB:PBIO) has received an upgraded "outperform" rating from its prior "neutral" by analysts at Zacks Investment Research Thursday, who called the life science company's valuation "very attractive at this time". 

]]>
Thu, 29 Nov 2012 18:52:00 -0500 https://www.proactiveinvestors.com/companies/news/91589/pressure-biosciences-upgraded-to-outperform-by-zacks-as-pct-platform-increasingly-gains-recognition-37966.html
Pressure BioSciences says Ironridge converts final series E preferred stock into common shares https://www.proactiveinvestors.com/companies/news/91552/pressure-biosciences-says-ironridge-converts-final-series-e-preferred-stock-into-common-shares-37902.html Wed, 28 Nov 2012 18:58:00 -0500 https://www.proactiveinvestors.com/companies/news/91552/pressure-biosciences-says-ironridge-converts-final-series-e-preferred-stock-into-common-shares-37902.html Pressure BioSciences partners with UK-based Constant Systems to expand international reach https://www.proactiveinvestors.com/companies/news/91465/pressure-biosciences-partners-with-uk-based-constant-systems-to-expand-international-reach--37774.html Pressure BioSciences (OTCQB:PBIO) has inked a two-way strategic marketing, selling and distribution agreement with UK-based biomedical product provider Constant Systems, with the deal to expand Pressure's international reach into 12 additional countries. 

]]>
Mon, 26 Nov 2012 15:19:00 -0500 https://www.proactiveinvestors.com/companies/news/91465/pressure-biosciences-partners-with-uk-based-constant-systems-to-expand-international-reach--37774.html
Pressure BioSciences posts 40% rise in Q3 revenues, narrows loss https://www.proactiveinvestors.com/companies/news/91243/pressure-biosciences-posts-40-rise-in-q3-revenues-narrows-loss-37371.html Pressure BioSciences (OTCQB: PBIO) has posted a 40 per cent increase in revenues for its third quarter, reporting record sales of its pressure cycling technology (PCT) products. 

]]>
Thu, 15 Nov 2012 17:34:00 -0500 https://www.proactiveinvestors.com/companies/news/91243/pressure-biosciences-posts-40-rise-in-q3-revenues-narrows-loss-37371.html
Pressure BioSciences could see "significant opportunity" from Cole-Parmer deal - Seeking Alpha https://www.proactiveinvestors.com/companies/news/91118/pressure-biosciences-could-see-significant-opportunity-from-cole-parmer-deal-seeking-alpha-37185.html Mon, 12 Nov 2012 14:00:00 -0500 https://www.proactiveinvestors.com/companies/news/91118/pressure-biosciences-could-see-significant-opportunity-from-cole-parmer-deal-seeking-alpha-37185.html Pressure BioSciences says PCT platform benefits highlighted at a recent international scientific conference https://www.proactiveinvestors.com/companies/news/90940/pressure-biosciences-says-pct-platform-benefits-highlighted-at-a-recent-international-scientific-conference-36874.html Fri, 02 Nov 2012 18:15:00 -0400 https://www.proactiveinvestors.com/companies/news/90940/pressure-biosciences-says-pct-platform-benefits-highlighted-at-a-recent-international-scientific-conference-36874.html Pressure Biosciences "banging at the door" of life sciences market, Seraphim says https://www.proactiveinvestors.com/companies/news/90870/pressure-biosciences-banging-at-the-door-of-life-sciences-market-seraphim-says-36744.html Wed, 31 Oct 2012 17:56:00 -0400 https://www.proactiveinvestors.com/companies/news/90870/pressure-biosciences-banging-at-the-door-of-life-sciences-market-seraphim-says-36744.html Pressure BioSciences says keynote speech will increase visibility of PCT platform https://www.proactiveinvestors.com/companies/news/90863/pressure-biosciences-says-keynote-speech-will-increase-visibility-of-pct-platform-36737.html Wed, 31 Oct 2012 16:57:00 -0400 https://www.proactiveinvestors.com/companies/news/90863/pressure-biosciences-says-keynote-speech-will-increase-visibility-of-pct-platform-36737.html Pressure BioSciences says 2 research groups' studies validate PCT technology for forensics https://www.proactiveinvestors.com/companies/news/90537/pressure-biosciences-says-2-research-groups-studies-validate-pct-technology-for-forensics-36195.html Thu, 18 Oct 2012 17:52:00 -0400 https://www.proactiveinvestors.com/companies/news/90537/pressure-biosciences-says-2-research-groups-studies-validate-pct-technology-for-forensics-36195.html ViewTrade starts Pressure Biosciences at "Speculative Buy" with $1.12 target https://www.proactiveinvestors.com/companies/news/89880/viewtrade-starts-pressure-biosciences-at-speculative-buy-with-112-target-35145.html  

ViewTrade Securities has started coverage on Pressure Biosciences (OTCQB:PBIO) with a "Speculative Buy" rating and $1.12 price target.

 

]]>
Tue, 25 Sep 2012 17:11:00 -0400 https://www.proactiveinvestors.com/companies/news/89880/viewtrade-starts-pressure-biosciences-at-speculative-buy-with-112-target-35145.html
Pressure BioSciences Q2 revenue rises 70%, trend expected to continue https://www.proactiveinvestors.com/companies/news/88668/pressure-biosciences-q2-revenue-rises-70-trend-expected-to-continue-33262.html Tue, 14 Aug 2012 18:01:00 -0400 https://www.proactiveinvestors.com/companies/news/88668/pressure-biosciences-q2-revenue-rises-70-trend-expected-to-continue-33262.html Pressure BioSciences extends global sales reach with new distribution deals https://www.proactiveinvestors.com/companies/news/87855/pressure-biosciences-extends-global-sales-reach-with-new-distribution-deals-31895.html Thu, 12 Jul 2012 17:37:00 -0400 https://www.proactiveinvestors.com/companies/news/87855/pressure-biosciences-extends-global-sales-reach-with-new-distribution-deals-31895.html Pressure BioSciences inks deal for initial $600,000 tranche of $1.2-mln financing https://www.proactiveinvestors.com/companies/news/87547/pressure-biosciences-inks-deal-for-initial-600000-tranche-of-12-mln-financing-31385.html Tue, 03 Jul 2012 17:08:00 -0400 https://www.proactiveinvestors.com/companies/news/87547/pressure-biosciences-inks-deal-for-initial-600000-tranche-of-12-mln-financing-31385.html Pressure BioSciences, LEAP Technologies sign key co-operation deal https://www.proactiveinvestors.com/companies/news/85942/pressure-biosciences-leap-technologies-sign-key-co-operation-deal-28728.html Mon, 07 May 2012 16:12:00 -0400 https://www.proactiveinvestors.com/companies/news/85942/pressure-biosciences-leap-technologies-sign-key-co-operation-deal-28728.html Pressure BioSciences expands license deal with Target Discovery https://www.proactiveinvestors.com/companies/news/85582/pressure-biosciences-expands-license-deal-with-target-discovery--28089.html Mon, 23 Apr 2012 19:07:00 -0400 https://www.proactiveinvestors.com/companies/news/85582/pressure-biosciences-expands-license-deal-with-target-discovery--28089.html Pressure BioSciences inks "favourable financing" deal, says Zacks Equity Research https://www.proactiveinvestors.com/companies/news/85472/pressure-biosciences-inks-favourable-financing-deal-says-zacks-equity-research--27911.html Wed, 18 Apr 2012 18:38:00 -0400 https://www.proactiveinvestors.com/companies/news/85472/pressure-biosciences-inks-favourable-financing-deal-says-zacks-equity-research--27911.html Pressure BioSciences featured on BiotechStockTrader.com https://www.proactiveinvestors.com/companies/news/84535/pressure-biosciences-featured-on-biotechstocktradercom-26277.html Wed, 14 Mar 2012 20:03:00 -0400 https://www.proactiveinvestors.com/companies/news/84535/pressure-biosciences-featured-on-biotechstocktradercom-26277.html Pressure BioSciences to collaborate with Henry C. Lee Institute on PCT platform for wide-ranging forensic uses https://www.proactiveinvestors.com/companies/news/84387/pressure-biosciences-to-collaborate-with-henry-c-lee-institute-on-pct-platform-for-wide-ranging-forensic-uses-26047.html Fri, 09 Mar 2012 15:25:00 -0500 https://www.proactiveinvestors.com/companies/news/84387/pressure-biosciences-to-collaborate-with-henry-c-lee-institute-on-pct-platform-for-wide-ranging-forensic-uses-26047.html Pressure BioSciences inks another distribution deal for PCT products in Benelux region https://www.proactiveinvestors.com/companies/news/84168/pressure-biosciences-inks-another-distribution-deal-for-pct-products-in-benelux-region-25688.html Thu, 01 Mar 2012 18:54:00 -0500 https://www.proactiveinvestors.com/companies/news/84168/pressure-biosciences-inks-another-distribution-deal-for-pct-products-in-benelux-region-25688.html AMI Research says Pressure BioSciences "poised for growth", starts coverage with "buy" rating https://www.proactiveinvestors.com/companies/news/84126/ami-research-says-pressure-biosciences-poised-for-growth-starts-coverage-with-buy-rating-25613.html Wed, 29 Feb 2012 17:56:00 -0500 https://www.proactiveinvestors.com/companies/news/84126/ami-research-says-pressure-biosciences-poised-for-growth-starts-coverage-with-buy-rating-25613.html Pressure BioSciences CEO Schumacher featured in BioMed Reports article https://www.proactiveinvestors.com/companies/news/84045/pressure-biosciences-ceo-schumacher-featured-in-biomed-reports-article-25479.html Mon, 27 Feb 2012 18:35:00 -0500 https://www.proactiveinvestors.com/companies/news/84045/pressure-biosciences-ceo-schumacher-featured-in-biomed-reports-article-25479.html Pressure BioSciences closes $800,000 private placement financing https://www.proactiveinvestors.com/companies/news/83552/pressure-biosciences-closes-800000-private-placement-financing-24707.html Wed, 08 Feb 2012 18:44:00 -0500 https://www.proactiveinvestors.com/companies/news/83552/pressure-biosciences-closes-800000-private-placement-financing-24707.html Pressure BioSciences says Florida university receives $350,000 grant for PCT-based rape processing method https://www.proactiveinvestors.com/companies/news/83297/pressure-biosciences-says-florida-university-receives-350000-grant-for-pct-based-rape-processing-method-24272.html Tue, 31 Jan 2012 16:18:00 -0500 https://www.proactiveinvestors.com/companies/news/83297/pressure-biosciences-says-florida-university-receives-350000-grant-for-pct-based-rape-processing-method-24272.html Pressure BioSciences reports significant progress in new method for processing rape kits https://www.proactiveinvestors.com/companies/news/83117/pressure-biosciences-reports-significant-progress-in-new-method-for-processing-rape-kits-24004.html Wed, 25 Jan 2012 14:39:00 -0500 https://www.proactiveinvestors.com/companies/news/83117/pressure-biosciences-reports-significant-progress-in-new-method-for-processing-rape-kits-24004.html Pressure BioSciences shares surge on co-marketing/selling deal with Digilab https://www.proactiveinvestors.com/companies/news/82730/pressure-biosciences-shares-surge-on-co-marketingselling-deal-with-digilab-23360.html Wed, 11 Jan 2012 18:35:00 -0500 https://www.proactiveinvestors.com/companies/news/82730/pressure-biosciences-shares-surge-on-co-marketingselling-deal-with-digilab-23360.html Pressure BioSciences signs distribution deal for Germany and Switzerland https://www.proactiveinvestors.com/companies/news/82299/pressure-biosciences-signs-distribution-deal-for-germany-and-switzerland-22682.html Mon, 19 Dec 2011 14:49:00 -0500 https://www.proactiveinvestors.com/companies/news/82299/pressure-biosciences-signs-distribution-deal-for-germany-and-switzerland-22682.html Pressure BioSciences "poised to grow dramatically" in fiscal 2012, says Zacks Research https://www.proactiveinvestors.com/companies/news/82237/pressure-biosciences-poised-to-grow-dramatically-in-fiscal-2012-says-zacks-research-22576.html Thu, 15 Dec 2011 16:54:00 -0500 https://www.proactiveinvestors.com/companies/news/82237/pressure-biosciences-poised-to-grow-dramatically-in-fiscal-2012-says-zacks-research-22576.html Pressure BioSciences granted request for continued listing by Nasdaq panel https://www.proactiveinvestors.com/companies/news/82066/pressure-biosciences-granted-request-for-continued-listing-by-nasdaq-panel-22272.html Thu, 08 Dec 2011 19:27:00 -0500 https://www.proactiveinvestors.com/companies/news/82066/pressure-biosciences-granted-request-for-continued-listing-by-nasdaq-panel-22272.html Pressure BioSciences goes full steam ahead into 2012 https://www.proactiveinvestors.com/companies/news/81847/pressure-biosciences-goes-full-steam-ahead-into-2012-21858.html Life sciences company Pressure BioSciences (NASDAQ:PBIO) has seen a host of developments of late, including the successful raising of nearly $1 million and meeting its sales targets for the third quarter, putting the company on pace for steady growth in 2012.

]]>
Wed, 30 Nov 2011 19:08:00 -0500 https://www.proactiveinvestors.com/companies/news/81847/pressure-biosciences-goes-full-steam-ahead-into-2012-21858.html
Pressure BioSciences announces Q3 revenue rises 47% sequentially https://www.proactiveinvestors.com/companies/news/81449/pressure-biosciences-announces-q3-revenue-rises-47-sequentially--21109.html Tue, 15 Nov 2011 16:36:00 -0500 https://www.proactiveinvestors.com/companies/news/81449/pressure-biosciences-announces-q3-revenue-rises-47-sequentially--21109.html Pressure BioSciences announces $843,000 registered direct offering https://www.proactiveinvestors.com/companies/news/81319/pressure-biosciences-announces-843000-registered-direct-offering-20852.html Thu, 10 Nov 2011 14:17:00 -0500 https://www.proactiveinvestors.com/companies/news/81319/pressure-biosciences-announces-843000-registered-direct-offering-20852.html Pressure BioSciences’ core pressure cycling technology to become scientific "investigators choice" https://www.proactiveinvestors.com/companies/news/80787/pressure-biosciences-core-pressure-cycling-technology-to-become-scientific-investigators-choice-20018.html Pressure BioSciences (PBI) (NASDAQ:PBIO) is a company operating in the life sciences market, whose pressure cycling technology (PCT) used to extract cell components has a myriad of potential target industries, and according to CEO Richard T. Schumacher, is among the most under-appreciated businesses listed on the Nasdaq today, with enormous growth potential.

]]>
Mon, 24 Oct 2011 14:11:00 -0400 https://www.proactiveinvestors.com/companies/news/80787/pressure-biosciences-core-pressure-cycling-technology-to-become-scientific-investigators-choice-20018.html
Pressure BioSciences completes preferred stock conversion, simplifies capital structure https://www.proactiveinvestors.com/companies/news/80677/pressure-biosciences-completes-preferred-stock-conversion-simplifies-capital-structure-19842.html Tue, 18 Oct 2011 20:06:00 -0400 https://www.proactiveinvestors.com/companies/news/80677/pressure-biosciences-completes-preferred-stock-conversion-simplifies-capital-structure-19842.html Pressure BioSciences gets $649,000 grant from US Defence Dept. https://www.proactiveinvestors.com/companies/news/80554/pressure-biosciences-gets-649000-grant-from-us-defence-dept-19637.html Thu, 13 Oct 2011 19:36:00 -0400 https://www.proactiveinvestors.com/companies/news/80554/pressure-biosciences-gets-649000-grant-from-us-defence-dept-19637.html Pressure Biosciences' Barocycler makes primetime US TV appearance on CSI:NY https://www.proactiveinvestors.com/companies/news/80062/pressure-biosciences-barocycler-makes-primetime-us-tv-appearance-on-csiny-18807.html Pressure Biosciences (NASDAQ:PBIO) said that its sample preparation Barocycler Instrument appeared in the season opener of the highly-watched CBS crime show CSI:NY on Friday night, in a scene alongside lead actor Gary Sinise.

]]>
Mon, 26 Sep 2011 12:05:00 -0400 https://www.proactiveinvestors.com/companies/news/80062/pressure-biosciences-barocycler-makes-primetime-us-tv-appearance-on-csiny-18807.html